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ABSTRACT 
Tuberculosis (TB) is a deadly pulmonary disease with an especially high mortality 
rate in immuno-compromised populations, specifically children and HIV positive 
individuals. The causative agent, Mycobacterium tuberculosis (Mtb), is very slow 
growing—making both diagnosis and development of effective treatments very difficult. 
Whole-animal fluorescence imaging with recombinant or fluorescently-tagged pathogens 
or cells enables real time analysis of disease progression and treatment response in live 
animals. However, tissue absorption limits penetration of fluorescence excitation light, 
particularly in the visible wavelength range, resulting in reduced sensitivity to deep 
targets. In this dissertation, the use of an optical fiber bundle to deliver light into the mouse 
lung to excite fluorescent bacteria was shown to circumvent tissue absorption of excitation 
light in a whole-animal imaging system. A fiber-optic fluorescence microendoscope was 
integrated into a whole-body imaging system for in-vivo Mtb detection. 
First, we employed this technology to improve detection of recombinant reporter 
strains of tdTomato-expressing Mycobacterium bovis BCG (Bacillus Calmette Guerin) 
bacteria in the mouse lung. Using this technique, the threshold of detection was measured 
as 103 colony forming units (CFU) during pulmonary infection. In comparison, the 
threshold of detection for whole-animal fluorescence imaging using standard epi-
illumination was greater than 106 CFU. 
We next exploited an endogenous enzyme of Mtb (β-lactamase, or BlaC) using a 
BlaC-specific NIR fluorogenic substrate. In the presence of BlaC, this substrate is cleaved 
and becomes fluorescent. Using intravital illumination of the lung with the fiber 
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microendoscope to excite this probe, the sensitivity of the optical system increases over 
trans-illumination and epi-illumination methods of whole-body fluorescence imaging. We 
demonstrated that the integration of these optical imaging technologies with a BlaC-
specific fluorescent reporter probe increases the system sensitivity by two orders of 
magnitude, allowing detection down to ~100 colony forming unit (CFU) infection. This 
lower detection threshold enables the study of early stage bacterial infection and could 
allow for longitudinal studies of disease pathogenesis and therapeutic efficacy with 
multiple time points measured in a single animal. 
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CHAPTER I 
INTRODUCTION 
The ultimate goal of all the experiments in this dissertation is to develop a new 
imaging technique for localized high-resolution imaging and simultaneous intravital 
fluorescence excitation in whole-animal imaging to improve the level of detection of 
bacteria – Tuberculosis (TB) - in live animals. The two main projects contained in this 
dissertation can be split into two aims: 1) whole-animal imaging of recombinant strains of 
bacteria using an intravital illumination source to enhance the detection threshold of 
standard whole-animal imaging systems; and 2) the combination of the developed imaging 
technique with reporter enzyme fluorescence (REF) technology to enable whole-body 
imaging that does not require recombinant strains in an effort to facilitate potential 
translation to clinical pediatric applications. 
Chapter II, covers the background on TB disease and the optical techniques for TB 
detection. In chapter III, the importance of using animal models for bacterial detection and 
the different techniques for animal’s infection is presented. Chapter IV demonstrates the 
optical system design for fiber-optic microendoscope and the diffusing fiber, as well as 
the integration of the fiber-optic microendoscope into the whole-animal imaging system. 
The results for preliminary experiment are also presented in chapter IV. In chapter V, we 
employ the intravital illumination microendoscope integrated to the whole-animal imager 
for detection of recombinant reporter strains of tdTomato-expressing Mycobacterium 
bovis BCG bacteria in the mouse lung. In chapter VI, the integrated imaging system in 
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combined with a BlaC-specific NIR fluorogenic substrate and REF technology is used to 
improve the detection sensitivity of the developed imaging technique. Chapter VII 
summarizes the major contribution of this dissertation, as well as the future work. 
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CHAPTER II 
OPTICAL DETECTION OF TUBERCULOSIS 
2.1 Tuberculosis infection 
Infectious diseases are the most common cause of death in humans worldwide, 
especially in developing countries. It has been reported that 95% of reported cases of 
infectious diseases occur in low income countries, where infectious disease accounts for 
over half of all neonatal deaths  [1]. 
Tuberculosis (TB) remains a major global health problem, infecting one third of 
the world’s population based on World Health Organization (WHO) estimations [1]. 
Although TB disease seems to be more common in developing countries, it is also a major 
problem in industrialized countries. High rate of immigration, rapid increase in poverty, 
poor nutrition, war, and limited access to proper medication are the most important factors 
leading to revival of TB in these countries [2]. 
TB, caused by an acid-fast bacillus Mycobacterium tuberculosis (Mtb), is 
transmitted via the respiratory route. Infection primarily occurs in the lungs, but it can also 
affect organs in the central nervous system, lymphatic system, and circulatory system 
among others via hematogenous spread. The bacteria in the lungs multiply and cause 
pneumonia along with chest pain, coughing up blood, and a prolonged cough. In addition, 
lymph nodes near the heart and lungs become enlarged. As the TB tries to spread to other 
parts of the body, it is often interrupted by the body's immune system. If the body's 
immune system is unable to fight TB (HIV infected people), the disease returns to an 
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active state with pneumonia and damage to kidneys, bones, and the meninges that line the 
spinal cord and brain [3, 4]. This risk is increased by 20-30 times if co-infected with HIV 
[1].  
TB is a major cause of illness and death worldwide, especially in Asia (56%) and 
Africa (29%). As show in Figure 1, in 2013, there were an estimated 9 million incident 
cases of TB (range, 8.6 million-9.4 million) globally, equivalent to 126 cases per 100,000 
population. Also, there were an estimated 1.5 million TB death in 2013, which were about 
1.1 million among HIV-negative people and 360,000 among HIV-positive people. TB is 
second only to HIV/AIDS as the greatest killer worldwide due to a single infectious agent 
and is the leading killer of people living with HIV [1, 3]. 
 
 
 
Figure 1: Estimated TB incidence rate, 2013 [1] 
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TB germs are spread person to person through the air when a person with untreated 
pulmonary TB coughs, sneezes, laughs, and sings. However, it is not spread by sharing 
silverware or cups, sharing cigarettes, or sharing saliva when kissing someone. Prolonged 
exposure to a person with untreated TB usually is necessary for infection to occur. Anyone 
can get tuberculosis, but certain factors can increase your risk of the disease, such as: 
people with weakened immune system (HIV/AIDS, diabetes, end-stage kidney disease, 
etc.), people who are travelling or are living or have been born in a high risk area (sub-
saharan Africa, India, China, Russia, Pakistan), poverty and substance abuse (lack of 
medical care, substance abuse, tobacco use), and regular contact with people who are ill 
(family members, friends, coworkers, nurses) [1, 3]. 
Mtb is mainly considered an airborne pathogen. One of the possible outcomes for 
a person encountering Mtb is that the bacillus can be immediately destroyed by the host's 
innate responses. The other possibility is that the person who is infected with Mtb develops 
active TB within a time frame of 1 to 3 years. This group of people are unable to develop 
a protective response in time to prevent the disease. The final possible outcome is that a 
majority of people infected with Mtb have a clinically latent infection. This group of 
people show positive purified protein derivative (PPD) by skin test, but they do not show 
any clinical symptoms of TB and are not contagious to others. However, In approximately 
5 to 10% of latently infected persons, the infection will reactivate and cause active 
tuberculosis [4, 5]. 
The infection process can be divided into three stages. First, aerosol droplets 
containing Mtb are transmitted from an infected individual to a healthy person. Once Mtb 
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enters the lungs, it resides within alveolar macrophages (AMs) and dendritic cells. In the 
primary infection, Mtb replicates within the macrophage and induces cytokines that 
initiate the mild inflammatory response in the lungs. Second, AMs and lymphocytes 
migrate to the site of infection and form cell-mediated immunity and granulomas, where 
macrophages become activated to kill intracellular Mtb. Granulomas are responsible to 
segregate the infection to prevent spread to the other parts of the lung and to other organs, 
as well as concentrate the immune response at the site of infection. At this stage more than 
90% of infected people remain asymptomatic, and live bacilli have been isolated from 
granulomas or tubercles in the lungs of persons with clinically inactive tuberculosis. 
Finally, when latent TB is reactivated and causes active disease, either because of a decline 
in the host’s immunity or a failure to develop and maintain immune signals [4, 6].  
Although TB treatment has been successful over the past 25 years using a six-
month course of antimicrobial drugs, multi-drug resistant strains of Mtb remain a 
significant challenge to the development of effective new antimicrobial therapies [7, 8]. 
In addition, the efficiency of Mycobacterium bovis Bacillus Calmette Guérin (BCG), 
which is the current vaccine to prevent TB infections worldwide, is variable depending 
upon the population being vaccinated, from 0-80% [9, 10]. Early diagnosis and proper 
treatment of TB could reduce the rate of TB transmission worldwide and decrease the risk 
of latent TB infection (LTBI) to become active. 
 
 
 
7 
2.2 TB diagnosis techniques 
In order to improve the sensitivity and specificity of methods for TB detection, 
there is a growing need for more accurate and rapid diagnostic techniques. Currently, there 
are several diagnostic tests that are used to determine if a person has been infected with 
TB bacteria: the Tuberculin skin test (TST), TB blood tests, sputum smear microscopy, 
sputum culture, and chest x-ray. 
TST or intradermal Mantoux is the oldest diagnostic test and has been used for TB 
infection since 1910. It is more widely used in countries with low rates of TB to test for 
LTBI. Although TST has poor specificity in BCG-vaccinated persons, low sensitivity in 
people with weakened cellular immunity (young children, HIV infected patients), and 
several logistic drawbacks, it is still included in the WHO latest recommendations for TB 
control. TST is performed by injecting 0.1 ml of tuberculin protein–purified derivative 
(PPD) into the inner surface of the lower part of the arm, which forms a culture filtrate of 
tubercle bacilli containing over 200 antigens common both in BCG vaccine and in most 
non tuberculosis bacteria. In other words, TST uses the fact that LTBI produces a strong 
cell-mediated immune response by measuring the delayed-type hypersensitivity (DTH) 
response to intradermal inoculation of tuberculin PPD after 48-72 hours of the initial 
administration (Figure 2, left). In addition to errors of TST placement and reading, TST 
can produce both false positive (anamnestic immune reaction) and false negative (severe 
active TB or immunosuppressed patients) results. Therefore, TST test has low specificity 
and is not very powerful in diagnosis of LTBI [2, 11, 12]. 
8 
TB blood tests (also called interferon-γ release assays or IGRAs) measure how the 
immune system reacts to the TB bacteria. An IGRA measures how strong a person’s 
immune system reacts to TB bacteria by testing the person’s blood in a laboratory. Recent 
Mycobacterium genomics studies in the late 1990’s have identified a specific Mtb genomic 
segment named region of difference-1 (RD-1), that is deleted from all strains of BCG 
vaccine and non-tuberculosis environmental mycobacteria. Two proteins produced by 
genes in RD-1, early secretory antigenic target-6 (ESAT-6) and culture filtrate protein-10 
(CFP-10), are targets of T-cells in TB patients. The T-cells produce a complex response 
Figure 2: Schematic diagram of TST (left), ELISpot (center), and ELISA (right) for 
diagnosing Tuberculosis infection [11] 
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to these antigens, including specific cytokines. These assays work by detecting a cytokine 
called the interferon-γ cytokine. There are two IGRA blood tests that are commercially 
available for measurement of antigen-specific T-cell responses and have been approved 
by the U.S. Food and Drug Administration (FDA) and in some European countries: the 
QuantiFERON® TB Gold test, and the T-SPOT® TB test [2, 11, 12].  
The QuantiFERON® TB is based on whole blood enzyme-linked immunosorbent 
assay (ELISA) (developed in Australia in 1980, adapted for human use in the 1990s). The 
QuantiFERON® TB is a whole-blood ELISA, which measures the interferon (IFN) -γ 
concentration in the supernatant of a sample of diluted whole blood after 24 h of incubation 
with ESAT-6 and CFP-10 (Figure 2, right). This blood test has been recommended to 
replace TST. T-SPOT® TB test is based on ELISpot developed in UK in 1990. ELISpot 
is a rapid ex-vivo enzyme-linked immunospot assay which counts individual antigen-
specific T cells. In the presence of Mtb Infection, T cells become sensitized to ESAT-6 or 
CFP-10 in-vivo. In the overnight ELISpot assay, they release a cytokine, interferon (IFN)-
γ as they re-encounter these antigens ex-vivo (Figure 2, center). Compared to the other 
techniques, these blood tests are faster and simpler than microscopy techniques, more 
sensitive in detection of false negative LTBI cases and fewer false positive cases in BCG 
vaccinated people than TST [2, 11, 12]. 
Sputum smear microscopy remains the primary tool for the diagnosis of pulmonary 
tuberculosis in low-income and middle-income countries. It requires simple and 
inexpensive laboratory facilities, and when performed correctly, has an important role in 
rapidly identifying infectious cases specifically in areas where there is a high prevalence 
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of TB. However, sputum microscopy has several limitations for the diagnosis of TB in 
children and in HIV-positive individuals (smear-negative TB). Smear microscopy 
involves collecting two consecutive sputum specimens, fixing them on a glass slide, and 
then staining them with a dye that binds specifically to mycobacteria (making them easier 
to identify under a microscope). Smear microscopy for TB is sometimes called AFB 
testing, because mycobacteria are ‘acid-fast bacilli’ (AFB). This means that certain dyes 
adhere to the waxy coat of mycobacteria and remain visible even after rinsing with water 
and being briefly treated with a solution of acid-alcohol that strips the dye from the rest of 
the smear. Sputum microscopy can be used to diagnose people with infectious TB, monitor 
the progress of treatment, and confirm that the cure has been achieved [13, 14]. 
Culture is used to diagnose active Mtb infections, infections due to nontuberculous 
mycobacteria, or to determine whether TB-like symptoms are due to another cause. 
Sputum cultures can also be used to monitor the effectiveness of treatment and can help 
determine when a person is no longer infectious. Though this test is more sensitive than 
sputum smear microscopy, it takes longer for results to become available due to the slow 
growth rate of Mtb, which may take several weeks to months. Currently, sputum culture 
is the most sensitive technique for TB diagnosis [15].  
 Chest X-ray is usually done when the TB skin test result is positive or in the 
presence of symptoms of active TB such as a persistent cough, high fever, fatigue, or night 
sweats. An uncertain reaction to the TB skin test would require an X-ray because of a 
weakened immune system or a previous BCG vaccination. Chest X-rays may reveal 
advanced pulmonary TB, but can miss other less obvious forms [11, 12]. 
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Different approaches can be used for TB diagnosis, based on the available facilities 
and the infection stage (LTBI or pulmonary TB). Table 1 summarizes different approaches 
for TB diagnosis based on the different regions of the world. 
After completion of treatment for pulmonary TB, patients remain at risk for 
complications, including relapse (rates of 0-6% within 6 to 30 months), aspergilloma, 
bronchiectasis, broncholithiasis, fibrothorax, and possibly carcinoma. A copy of the chest 
radiograph at the time of completion of therapy should be provided to the patient to 
facilitate the diagnosis of late complications. Relapse after treatment indicates that viable 
Mtb complex may remain after treatment in some patients. Rate of relapse is higher in 
certain populations such as AIDS patients, non-compliant patients, and patients infected 
with resistant strains of Mtb. Methods to identify patients at risk of relapse and methods 
to monitor response to treatment would be desirable. Since radiographic resolution lags 
behind clinical improvement, sputum microscopy and sputum culture are currently the 
methods used to monitor the efficacy of treatment and outcome. However, since sputum 
microscopy is insensitive and sputum culture is time-consuming, supplementary rapid and 
sensitive monitoring methods would be advantageous [15]. 
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Table 1: TB diagnosis approaches in different regions 
Region Approaches 
H
ig
h
 b
u
rd
en
 o
f 
T
B
 
Sub-
Saharan 
Africa 
 Sputum smear acid-fast microscopy (pulmonary TB); takes multiple 
days to get the results 
 Sputum culture (pulmonary TB); takes weeks for results 
 Chest X-ray if sputum smear result was negative (pulmonary TB) 
India 
 Sputum smear acid-fast microscopy (pulmonary TB); 1 day to 
weeks to get results 
 Chest X-ray (pulmonary TB) 
China 
 Chest X-ray (pulmonary TB) 
 Sputum smear acid-fast microscopy (pulmonary TB); 1 day to 
weeks to get results 
 Sputum culture (pulmonary TB); takes weeks for results 
M
o
d
er
at
e 
b
u
rd
en
 o
f 
T
B
 Eastern 
Europe & 
Russia 
 Chest X-ray (pulmonary TB) 
 Sputum smear acid-fast microscopy (pulmonary TB); usually same 
day results 
 Sputum culture (pulmonary TB); takes weeks for results 
Central & 
South 
America   
 Skin test (LTBI); takes 1-2 days for results 
 Blood test (LTBI); takes 1-2 days for results 
 Chest X-ray (pulmonary TB) 
 Sputum smear acid-fast microscopy (pulmonary TB); 1 day to 
weeks to get results 
 Sputum culture (pulmonary TB); takes weeks for results 
L
o
w
 b
u
rd
en
 o
f 
T
B
 
Western 
Europe, 
US & 
Canada 
 
  
 Skin test (LTBI); takes 1-2 days for results 
 Blood test (LTBI); takes 1-2 days for results 
 Chest X-ray (pulmonary TB) 
 Sputum smear acid-fast microscopy (pulmonary TB); same day 
results 
 Sputum culture (pulmonary TB); takes weeks for results 
 Gastric aspirate smear acid-fast (pulmonary TB); pediatric 
diagnosis; same day results 
 Gastric aspirate culture (pulmonary TB); pediatric diagnosis; same 
day results; takes weeks for results 
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2.3 Fluorescence markers for TB detection 
 The use of green fluorescent protein (GFP), from the jelly fish Aequorea victoria, 
as a marker of gene expression in the nematode Caenorhabditis elegans was first 
introduced in 1994 [16]. During the next 15 years, a variety of fluorescent proteins (FPs) 
spanning the visible spectrum were introduced and developed. The emission peak of most 
FPs that are derived from GFP are in the blue, green, or yellow spectral range. Red FPs 
such as DsRed are mostly derived from other sea organism like Discosoma sp. 
 Appropriate excitation and emission wavelengths, photostability (the time for a FP 
to lose 50% of its initial emission), maturation speed (the time to form a full chromophore), 
and brightness (quantum yield × extinction coefficient) are some of the criteria for a 
fluorescent marker to be suitable for use in biophotonic imaging (BPI). Fluorescent 
markers in the red or the far red region of the spectrum are more suitable for BPI, because 
of the reduced absorption and deeper light penetration of red and near infrared (NIR) 
wavelengths in tissue [17, 18].  Table 2 summarizes some of the FPs that have been used 
to study bacterial infection.  
 
 
 
Table 2: Properties of the most suitable fluorescent proteins for BPI [18, 19] 
Class Protein 
Excitation 
(nm) 
Emission 
(nm) 
Origin 
Brightness  
(% DsRed) 
Photostability 
Maturation 
time (min) 
Far-red mPlum 590 649 DsRed 7 53 100 
Red mCherry 
tdTomato 
DsRed 
587 
554 
558 
610 
581 
583 
DsRed  
DsRed 
Discosoma sp. 
27 
160 
100 
96 
98 
15 
60 
~600 
Yellow-
Green 
EYFP 514 527  86 60  
        
Green EGFP 488 507 Aequo ea 
victoria 
57 174  
 14 
 
2.4 Biophotonic imaging techniques for bacterial detection 
Since the current techniques for monitoring TB over time in preclinical animal 
studies are costly and time consuming for processing (animal sacrifice, organ harvest, 
tissue homogenization, and colony forming units (CFU) counts that may take up to 6-
weeks) [18], the development of sensitive experimental techniques that could provide 
rapid feedback regarding the therapeutic and vaccine efficacy in animal models could 
greatly benefit the development of TB vaccines and treatment strategies. Optical sensing 
and imaging offers a promising noninvasive solution to monitor bacterial dynamics in the 
host over time with high sensitivity. Optical imaging techniques have been used in a wide 
variety of applications such as visualizing tissue anatomy on the microscopic scale using 
reflectance spectroscopy [19], pre-cancer detection using confocal microscopy [20], and 
noninvasive localization of a photonic signal using fluorescence whole animal imaging 
[21, 22]  (Table 3).   
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Table 3: Optical imaging methods. A, absorption; Fl, fluorescence; S, scattering; E, 
emission [11] 
Resolution Technique Contrast Depth 
Microscopic Epi-microscopy A, Fl 20 μm 
Confocal microscopy Fl 500 μm 
Multiphoton microscopy Fl 800 μm 
Mesoscopic Optical projection tomography A, Fl 15 mm 
Optical coherence tomography S 2 mm 
Laser speckle imaging S 1 mm 
Macroscopic Hyperspectral imaging A, S, Fl < 5 mm 
Endoscopy A, S, Fl < 5 mm 
Fluorescence reflectance imaging (FRI) A, Fl < 7 mm 
Diffuse optical tomography (DOT) A, Fl < 20 cm 
Fluorescence resonance imaging (FRI) A, Fl < 7 mm 
Fluorescence molecular tomography (FMT) Fl < 20 cm 
BPI of luciferase-catalyzed reactions (bioluminescent) or excited fluorescent 
molecules is a highly sensitive optical imaging technique, which allows real-time 
noninvasive assessment of microorganisms and their locations within intact living 
animals. BPI is achieved using sensitive photon detectors to directly measure the visible 
(VIS) light produced by these microorganisms [18]. As light travels through different 
organs (such as skin, muscles, and bones), the light distribution and light propagation can 
be observed and quantified within living animals. Recently, commercial optical imaging 
systems have been widely used to study the molecular and cellular mechanisms that 
underlie disease development and progression (Table 4). 
“Replacement” methods that avoid or replace the use of animals, “reduction” 
methods that minimize animal use, and “refinement” methods that minimize the animal’s 
pain, suffering, and distress are the “three R’s” that many countries promote as ethical 
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responsibilities when using animals in research. BPI techniques can result in refinement 
and reduction. Using conventional methods for modeling infectious diseases, large 
numbers of infected animals per group are sacrificed at specific time points for bacterial 
enumeration from excised tissue. 
However, using BPI techniques, which allow for real-time monitoring of infected 
animals simply by detecting and imaging the optical signal within one group of animals, 
the same experiment could be completed with just 6 to 8 animals. In addition, real-time 
monitoring of the same group of animals over time, allows for following the disease 
progression more precisely, by having each animal as its own control [18]. Furthermore, 
detected bioluminescence and fluorescence signal in BPI techniques can be used for 
quantification of bacterial numbers, which can result in significant refinements in in-vivo 
animal experiments, since the photonic signal can be used to estimate whether the animal 
will survive or die [22-24]. BPI techniques can also reduce the level of pain and/or stress 
for animals by reducing the need for invasive sampling procedures that may be needed for 
bacterial quantification in specific organs or fluids such as blood [25]. Finally, 
effectiveness of the inoculation method can also be evaluated by real-time data provided 
by BPI techniques, so any administration errors can be detected immediately, minimizing 
unnecessary pain, suffering, and discomfort for the animals [18]. 
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Table 4: Commercially available BPI instrumentation [19] 
Manufacturer Instruments Features Specifications 
Berthold 
Technologies 
NightOwl Bioluminescence; 
Fluorescence 
Various filters; tungsten 
halogen excitation source. 
    
Biospace Lab PhotoImager Bioluminescence; 
Fluorescence; 
Image freely 
moving animals 
Wide range 
excitation/emission filters; 
halogen excitation source. 
    
Perkin Elmer IVIS 
(various 
models) 
Bioluminescence; 
fluorescence; 
Digital X-ray; 
Image freely 
moving animals 
Wide range 
excitation/emission filters; 
software for 3D 
reconstruction using 
spectral scanning. 
    
Cambridge 
Research & 
Instrumentation 
(CRi) 
Maestro Fluorescence; 
Spectral scanning 
Tunable filter allows 
spectral scanning; xenon 
excitation source. 
    
Carestream 
Health 
Kodak In -
vivo Imaging 
Systems 
Bioluminescence; 
fluorescence; 
Digital X-ray 
Various excitation/emission 
filters; xenon excitation 
source. 
    
Li-Cor 
Biosciences 
Pearl; 
Odyssey 
Imager + 
Mousepod 
NIR fluorescence 2-channel laser excitation 
    
VisEn FMT 2500 
Imaging 
system 
NIR fluorescence; 
Reflectance 
imaging and 
Quantitative 
Tomography 
Multimodality 
adaptors for 
CT/MR/PET 
2-channel laser excitation 
    
UVP iBox Scientia 
Small 
Animal 
Imaging  
Bioluminescence; 
Fluorescence 
Various excitation/emission 
filters 
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2.4.1 Properties of light propagation through tissue 
 Different factors can affect the sensitivity of the BPI techniques, such as: 
sensitivity of the detection system, level of fluorophore/luciferase excitation, 
excitation/emission wavelength, tissue type and tissue depth, whether the animal has fur 
or is pigmented, and tissue auto-fluorescence/luminescence background. However, the 
main challenges in optical imaging  are related to light propagation through tissue 
(scattering and absorption), and tissue auto-fluorescence background signal within living 
animals [18]. 
 When VIS or NIR photons interact with tissue, they highly scatter within the tissue 
and follow a diffusive path. In addition, their intensity (I) reduces after passing through 
tissue depth (d) based on the Beer-Lambert law 𝐼(𝑑) = 𝐼0𝑒
−𝜇𝑑, where µ is the coefficient 
of absorption and I0 is the incident intensity [26] . Endogenous chromophores, especially 
hemoglobin within the VIS range (400-760 nm), absorbs light within tissues in the blue 
and green part of the VIS spectrum, however its absorption reduces in longer wavelengths 
(> 600 nm), which allows red light transmission through several centimeters in tissue [27]. 
In addition to hemoglobin, melanin also contributes in light absorption in pigmented 
animals, so using albino animals for any optical imaging will minimize this problem. Due 
to the different interactions of light within the tissue and its significant impact on how 
much excitation light can travel from the surface to the target tissue, there is a high demand 
to develop highly sensitive optical imaging techniques that can reduce tissue absorption 
and auto-fluorescence.  
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Bioluminescence imaging techniques that rely on light-tight enclosures and 
transgenic cells expressing the enzyme luciferase are more sensitive than fluorescence 
imaging techniques because of the higher signal-to-noise ratio. The level of tissue auto-
fluorescence background in-vivo is higher than luminescence background; auto-
fluorescence is due to endogenous fluorophores such as keratin, porphyrins, NADH, 
collagen and elastin. Auto-fluorescence is almost uniform in the green and red spectral 
regions over the entire animal, however it is more concentrated in the intestinal area in 
far-red and NIR spectral regions, due to the presence of chlorophyll in the animal’s diet 
[28]. Alternative available diets such as alfalfa-free diet and a purified diet can 
significantly reduce the level of tissue auto-fluorescence in the red and NIR region [29]. 
Also, using advanced spectral unmixing algorithms can improve the signal-to-noise ratio 
by separating auto-fluorescence background from the specific signal [30]. 
 
2.4.2 Fluorescence imaging  
 Optical fluorescence imaging is an increasingly widespread technique in biology 
due to advances in fluorescent proteins, dyes, and probes that facilitate noninvasive 
imaging of gene expression, protein functions and interactions, and a variety of cellular 
processes [31, 32]. Different fluorescence imaging techniques offer imaging from the 
range of macroscopic imaging (small-animal whole-body imaging) to microscopic 
resolution imaging and video-rate scans [33-35], as well as methods that can operate at 
resolution beyond the diffraction limit and image single molecules. 
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2.4.2.1 Overview of whole animal imaging  
 Whole-body fluorescence optical imaging of animal models is a new and 
promising technique to study the molecular and cellular mechanisms that underlie disease 
development and progression, as well as gene expression by employing co-expression of 
fluorescent markers. This optical imaging technique has been widely used in noninvasive 
cancer studies, growth monitoring of tumors, and the effects of chemotherapy on tumor 
size using recombinant fluorescent cancer cells [21, 36-39], and recently in the study of 
bacterial infection dynamics [40]. 
 In whole-body imaging, the subject is illuminated with a broad-band light passing 
through an excitation filter, which is specified for the excitation wavelength of the 
fluorophore of interest. Whole-body optical imaging can be performed in epi-illumination 
and trans-illumination. In epi-illumination mode, the light source is located on the same 
side of the body as the detector; in contrast, in trans-illumination mode, the light source is 
located on the opposite side of the body from the detector [18]. Figure 3 shows the 
schematic of the trans-illumination IVIS spectrum whole-body imaging system. Trans-
illumination mode generally is more efficient in imaging signals located deeper inside the 
body. The resulting emission signal collected from the whole body is then captured in a 
completely dark chamber. Depending on the strength and location of the fluorescence 
signal, image acquisition can take from seconds to minutes. Specific bandwidth emission 
filters are selected to capture the desired emission spectrum. High sensitivity detectors 
have enabled detection of low numbers of cells in-vivo excited by epi- or trans-
illumination. CCD cameras encode the intensity of the incident photons spatially, which 
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are shown as pseudo color images overlapped on the photographic images for spatial 
registration. To evaluate the results, data are quantified over the region of interest and 
reported as photon flux or photon efficiency [18].  
 
 
 
  
 
 
Whole-body imaging has some intrinsic limitations related to the interaction of 
light with tissue components. Light scattering and absorption by tissue components cause 
signal attenuation and loss of resolution, and will diminish the ability to detect and resolve 
small populations of cells or pathogens deep inside the animal body, such as in the lung. 
Additionally, contribution of autofluorescence in the visible range, particularly from skin 
in epi-illumination, increases background and complicates signal detection even with 
spectral unmixing techniques. Figure 4 shows how light scattering and absorption can 
affect detected fluoresce signal in living tissue using simulated mouse models, imaged in 
epi-illumination mode. A tumor was located in the abdomen of each simulated animal, 
Figure 3: Schematic of the IVIS spectrum imaging system [31] 
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one close to the skin surface and the other near the axial center of animal. As figure 4 
shows, the intensity of the fluorescence signal coming from the tumor is dependent on its 
depth within the body [41]. 
Whole-body imaging, both in bioluminescence and fluorescence modes, has been 
used for the detection and imaging of different types of bacteria. Detection thresholds for 
whole-animal imaging of various types of bacterial infections is summarized in Table 5. 
Figure 4: Simulated mouse models to show how photon 
scattering can affect the fluorescence intensity in living 
tissue. A tumor was located in the abdomen in each 
model: (b) near the surface, (d) close to the axial center. 
(a) Shows the illuminated area by epi-illumination 
imaging. (c) and (e) show the detected fluorescence 
signal for the tumors in (b) and (c), respectively [42] 
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Table 5: Whole-animal imaging detection limit for bacterial detection 
Bacteria 
Fluoresce
nt probe 
Infection rout 
Location of 
bacteria 
Imaging Modality 
Detection limit 
(CFU) 
Reference 
Citrobacter 
rodentium 
- Oral In-vivo (gut) Bioluminescent 103 [42] 
S. aureus  
- 
Subcutaneous 
 Thigh 
injection  
In-vivo 
(subcutaneous, 
muscle tissue)  
Bioluminescent 
105 
(subcutaneous)
,  
106 (muscle)  
[43] 
M. bovis 
BCG 
EGFP subcutaneous In-vitro 
Fluorescence 
Trans-
illumination 
103 [40] 
M. bovis 
BCG 
tdTomato subcutaneous In-vitro 
Fluorescence 
Trans-
illumination 
102 [40] 
M. bovis 
BCG 
EGFP subcutaneous 
In-vivo 
(subcutaneous) 
Fluorescence 
Trans-
illumination  
107 [40] 
M. bovis 
BCG 
tdTomato subcutaneous 
In-vivo 
(subcutaneous) 
Fluorescence 
Trans-
illumination 
105 [40] 
M. bovis 
BCG 
CNIR5 
Intratracheal 
Aerosol 
In-vitro 
Fluorescence 
Trans-
illumination 
102 [44] 
M. bovis 
BCG 
CNIR5 
Intratracheal 
Aerosol 
In-vivo 
(Lung) 
Fluorescence 
Trans-
illumination 
104 [44] 
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2.4.2.2 Overview of fiber-optic fluorescence microscopy 
Optical fiber-based sensing and imaging techniques have been used in numerous 
areas of in-vivo studies and clinical practice. Optical fiber bundles have been exploited in 
high resolution confocal microendoscopes with high numerical aperture miniature 
objective lenses [45-47]. Simplified contact probe microendoscopes with wide-field 
illumination have more recently been developed [31, 48-50] and evaluated as tools for 
cancer detection [38, 51, 52]. 
Fiber optic techniques have been used for bacterial detection and sensing in biological 
samples. Fiber optic biosensors (FOB) have been employed to convert the laboratory-
based detection systems to smaller and more portable detection systems to allow the 
detection of whole bacterial cells [53, 54]. FOB usually composed of a light source which 
Figure 5: Fluorescent immunoassay using optical fiber [57] 
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generates the excitation light and an optical fiber containing immobilized bioreceptors, 
which transfer the excitation light to a sensitive detector [55]. A fiber-optic immune-
sensor has been developed for detection of Escherichia coli and Listeria monocytogenes in 
samples using Cynine-5 (Cy5) labeled polyclonal antibody (figure 5). Excitation light from 
the optical fiber excites Cy5 molecules, and the emitted fluorescence light is collected 
using a sensitive photodiode [56]. 
It has been shown that fiber-based intravital microendoscopy has the potential to 
image and detect low numbers of bacteria in vitro and in situ. A fiber-optic 
microendoscope with 4 μm resolution and 750 μm field of view has been developed to 
image mice subcutaneously and intra-tracheally infected with bacteria expressing 
tdTomato. The results show that the microendoscope’s limit of detection was 104 CFU in 
the case of skin samples and 107 CFU for lung samples [31]. By physically transmitting 
the excitation light source to the source of fluorescence in the tissue, detection levels can 
be greatly reduced, approaching the in vitro detection levels of whole-body imaging 
systems. Furthermore, intravital imaging of low numbers of bacteria with subcellular 
resolution may enable cellular localization of bacteria within the tissue and help to get a 
better understanding of dynamic processes in a minimally invasive manner. 
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CHAPTER III 
SMALL ANIMAL INFECTION AND IMAGING 
3.1 Introduction 
Small animal models play an important role in the study of cellular and molecular 
function and disease. Well-defined animal models allow the assessment of their biology, 
and provide useful information about different disease processes in its natural context in-
vivo, rather than in reductionist systems such as cells in culture dishes or on slides [18, 
57, 58].  
Among the wide variety of animal models to evaluate and test antibiotic drugs and 
vaccines, mice are the most widely used since they are relatively low cost, have a low 
animal-to-animal variability because of the availability of inbred strains, have a lifespan 
of 3 years, and have extensive physiological and molecular similarities to humans. Mice 
also need a smaller area for housing compared to other animals, such as guinea pigs and 
rabbits, and a large number of them can be housed in standard cages. Mice infected with 
strains of Mycobacterium tuberculosis are used as a model of the host protective immune 
response, since they are relatively resistant to mycobacterial infections [58-60]. 
3.2 Small animal infection with mycobacteria 
Infection with mycobacteria can be accomplished by a variety of routes, including 
intravenous inoculation of mice via the lateral tail vein or aerogenic routes. However, 
Mycobacterium infection via aerogenic route is the most physiologically normal way to 
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model human disease, since the natural route for tuberculosis infection in humans is the 
lung tissue. Mouse lungs can be infected intranasally or intratracheally. An aerosol of 
small droplet nuclei containing bacilli can be generated so that the inhalation of these 
droplets by the animal deposits them deeply into the alveoli of the lungs [59].  
 Following infection with mycobacteria, animals should be observed daily, and 
clinical symptoms recorded. Information such as daily body temperature and weight are 
useful to evaluate disease progression. In general, the progress of disease has five stages, 
based on the involvement of granulomatous, the cell types, the degree of lymphocyte 
organization, and the presence of destructive sequelae such as airway epithelium erosion 
and debris [61].  
 
3.1.1 Preparation of mycobacterial cultures for inoculation 
 Mycobacterial frozen stocks, either M. bovis BCG strains or M. tuberculosis 
strains, are routinely grown in culture both at 37˚C until an OD600=0.5 to 1 is obtained. 
Cultures can be stored in half medium/half sterile glycerol at −80˚C until use. In order to 
use the mycobacterial culture, the OD600 is measured and bacterial density determined 
based on this value. In general OD600 ≈ 1.0 represents 1.0 × 107 bacteria/ml for M. 
tuberculosis and M. bovis BCG. The target bacterial density can be calculated based on 
the initial density and the inoculation prepared by dilution or concentration of the initial 
culture [22]. 
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3.1.2 Routes of administration 
Administration of test substances, such as bacteria or fluorescent marker, to mice 
is one the most important experimental factors considered for evaluation of experimental 
results. The route of administration is dependent on the purpose of the experiment and the 
properties of the substrate. Mice should be protected from pain, distress, suffering, or at 
least these should be minimized. Among several ways to administer the bacteria or 
substrate to mice, the most common routes are subcutaneous (s.c.), intraperitoneal (i.p.) 
and intravenous (i.v.) injection, and intratracheal administration. The rate of absorption 
depends on the administration route. The bacteria/substrate usually absorbs immediately 
following i.v. injection, which is usually one-half or one-quarter as rapid as the other 
routes [62]. 
3.1.2.1 Subcutaneous administration (s.c.) 
Subcutaneous administration is usually easy and painless, such that a conscious 
mouse can be used. However, the absorption rate is lower than i.p. or i.v. injections. S.c. 
administrations is usually done over the interscapular or inguinal area in mice [62]. 
3.1.2.2 Intraperitoneal administration (i.p.) 
Intraperitoneal injection is the most common administration route, since it is 
technically simple to do. The absorption rate is longer than the i.v. route. The sensitivity 
of the tissue to substance and the lower tolerance to non-physiological pH of some 
solutions are potential limitations of this technique. Isotonic and large volume solutions 
can be administrated by this route [62]. 
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3.1.2.3 Intravenous administration (i.v.) 
Intravenous injection has some advantages over the other routes. Solutions with 
different pH level, high concentrations, or irritating elements can be administered via i.v. 
injection by keeping the injection rate slow and avoiding getting the solution outside of 
vein. Administration is usually made into the lateral tail vein, not into the dorsal tail vein. 
Other routes for i.v. injection such as ophthalmic plexus route, external jugular vein route, 
dorsal metatarsal vein route, and the sublingual vein route have been also reported [62]. 
3.1.2.4 Intratracheal administration 
In order to infect the mouse intratracheally, each animal is injected with a mixture 
of ketamine (100 mg/kg) and xylazine (10 mg/kg) for anesthesia. After the mouse is deeply 
anesthetized, using an otoscope and a guide wire, the catheter will be placed into the 
larynx. After placing the catheter, 50 μl of the bacterial solution will be pipetted on to the 
hub of the catheter followed by pipetting a small volume of air, to make sure all the 
solution is inhaled by the animal [22]. 
3.1.3 Bacterial enumeration 
After in-vivo experiments, determination of bacterial numbers can be 
accomplished by a number of direct or indirect methods, including standard plate counts, 
turbidimetric measurements, visual comparison of turbidity with a known standard, direct 
microscopic counts, cell mass determination, and measurement of cellular activity. In this 
project, we have performed bacterial enumeration after each in-vivo experiments using 
the standard plate count method, as described below. 
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A viable cell count is usually done by diluting the original sample, plating aliquots 
of the dilutions onto an appropriate culture medium, and then incubating the plates under 
proper conditions until colonies are formed. After incubation, the colonies are counted 
and, from knowledge of the dilution used, the original number of viable cells calculated. 
For accurate determination of the total number of viable cells, it is critical that each colony 
comes from only one cell, so chains and clumps of cells must be broken apart. However, 
since one is never sure that all such groups have been broken apart, the total number of 
viable cells is usually reported as colony-forming units (CFU) rather than cell numbers. 
This method of enumeration is relatively easy to perform and is much more sensitive than 
turbidimetric measurement. A major disadvantage, however, is the time required for 
dilutions, platings and incubations, as well as the time needed for media preparation. 
3.2 Small animal imaging 
Imaging of small laboratory animals (such as mice and rats) allows a noninvasive 
technique to evaluate in-vivo biological structures and functions, providing quantitative 
information on normal and/or diseased tissues. In addition, noninvasive small animal 
imaging facilitates longitudinal study of animal models of human diseases such as cancer, 
cardiovascular, and bacterial infections over the entire disease progression period, and 
monitoring of efficacy of different treatments and vaccines [63]. 
In this study, all animals were anesthetized with ketamine (100 mg/kg) and 
xylazine (10 mg/kg) before imaging. Animals were kept warm using a temperature-
controlled plate during and after imaging until they fully recovered from the anesthesia. 
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All imaging procedures were performed with great care to avoid tissue damage or animal 
suffering. 
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CHAPTER IV 
INTEGRATION OF WHOLE-ANIMAL OPTICAL IMAGING WITH FIBER OPTIC 
EXCITATION 
 
4.1 Introduction 
 In this study, we developed a fiber based excitation source/microendoscope that is 
coupled into a whole-animal imaging system in order to allow the excitation light to be 
delivered inside an animal model. This greatly enhances the intensity that can be achieved 
inside the animal, as the optical path length through tissue between the source and 
expected location of the fluorophore is minimized. In addition, such a system facilitates 
multi-scale imaging, where microscopic imaging can be obtained simultaneously with 
macroscopic whole-animal images in the case of using an imaging fiber bundle in the 
designed system. 
 
4.2 Intravital excitation sources for whole-animal imaging 
Three different optical fibers have been used in conjunction with whole-animal 
optical imaging to deliver the excitation light internally to improve the detection threshold 
of respiratory bacterial infection inside live animals, and their performances have been 
evaluated and compared; 1) a multimode fiber with 400 μm diameter core size (Thorlabs 
FT400UMT); 2) a diffuser fiber with 420 μm outer diameter; and 3) an optical imaging 
fiber bundle with 660 μm outer diameter (Fujikura FIGH-10-500N). Imaging studies were 
 33 
 
performed using 1) fiber-based intravital excitation and whole-animal imaging with the 
IVIS illumination blocked, and 2) IVIS epi-illumination and detection for comparison. 
 
4.2.1 Fiber optic microendoscope 
 Figure 6 illustrates the schematic of the fluorescence microendoscope that was 
constructed for bacterial detection and integrated into the whole-animal imaging system. 
The designed system can be used as an excitation source and/or as a microendoscope for 
multi-scale imaging. The basic design is similar to the system previously reported for use 
in bacterial imaging in situ [31]. A light source [light emitting diode (LED) or laser diode 
(LD)] is used for fluorescence excitation. Light from the source is filtered with an 
excitation filter, collimated with a condenser lens, and reflected off a dichroic mirror into 
the back aperture of an infinity-corrected objective lens focused on an optical fiber. 
Excitation light is guided by the optical fiber to its distal tip, which can be inserted into 
the airway of an animal model through an intratracheal catheter. For multiscale imaging 
purposes, the fluorescence emission light is then collected by the same or different fiber, 
filtered by a long-pass emission filter, and then focused onto a scientific grade 1.45 
megapixel CCD camera (QImaging Exi Blue) with 6.45 µm x 6.45 µm pixel size. All the 
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optical components of the microendoscope could be easily modified based on the desired 
fluorescent probe and its optical properties. 
 
 
 
 
4.2.2 Fiber optic diffuser 
 To enhance the excitation efficiency of fluorescent probes in the lung and reduce 
fluorescence background for whole animal fluorescence image detection, a fiber-coupled 
diffusing tip was fabricated and developed to illuminate the lumen of the airway, and its 
efficiency evaluated and compared to a multimode fiber and fiber bundle. The fiber 
diffuser was fabricated by casting a polymer rod (post-polymerized, UV-crosslinked, 
thermoset polyurethane) over the tip of the excitation fiber and media blasting the polymer 
to create defects, generating a light diffusing surface [64]. The length and width of the 
OL CCD 
LPF FL 
DM 
SPF 
CL 
Light source 
Figure 6: Illustration of the fiber-based microendoscope system. SPF: 
short-pass excitation filter; CL: collimating lens; DM: dichroic 
beamsplitter; OL: Microscope objective; FL: Focusing lens; LPF: long-
pass emission filter. 
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diffuser were optimized for transport through an endotracheal catheter in the mouse lung. 
Initial optical diffuser target metrics were ~5 mm in length to protrude past the tip of the 
catheter, and 420 µm in diameter to pass through the 600 µm inner diameter catheter. An 
image of a joint between an optical fiber and a cast SMP rod is shown in figure 7. 
An integrating sphere was used to measure the diffusion efficiency. The total 
radiant power emitted from the diffuser, including the light emitted from the diffusing 
surface and from the distal tip was measured by inserting the entire diffuser through an 
aperture slightly larger than the diffuser diameter into the integrating sphere. The diffuser 
was then withdrawn in 2-mm increments, and the power emitted from the distal portion 
inside the sphere was measured. The diffusion efficiencies over axial distances of 2, 4, 6, 
and 8 mm of the diffuser length were 8.5, 20, 36.7, and 58%, respectively. The percentage 
Optical 
Fiber tip 
diffuser rod 
Figure 7: Microscope image of an SMP diffuser 
showing attachment to the optical fiber and 
light distribution over the length of the diffuser. 
Magnification of the scope: 0.65 
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of incident light exiting the distal end of the diffuser was 42%, equal to the difference 
between the diffusion efficiency over 8 mm and 100%. A perfectly uniform diffuser with 
a diffusion efficiency of 96% over 8 mm would have values of 24, 48, 72, and 96% 
diffusion efficiency measured at 2, 4, 6, and 8 mm axial length, with 4% exiting the tip 
[64]. 
To measure the axial light emission profile along the length of the diffuser, an 800 
nm laser was used to illuminate the fiber with the attached 5 mm diffuser tip. The diffuser 
was manually rotated and reimaged to evaluate the circumferential uniformity. Figure 8 
shows the axial light emission profile along the 5 mm length of diffuser. 
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Figure 8: Axial light emission profile and circumferential uniformity of the diffuser tip 
attached to an optical fiber. 
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4.2.3 Integration of intravital excitation with whole-animal imager 
 Multi-scale imaging of bacterial infections was achieved by integrating the fiber 
excitation source or microendoscope into a whole animal imager (Perkin Elmer IVIS 
Lumina II). The fiber was inserted into the whole animal enclosure through an access port 
located on the side of the system, shown in figure 9. To prevent any external light from 
entering the system, a 0.5 mm hole was drilled into a rubber stopper (VWR 59580-069) 
which was then inserted into the access port opening. The fiber was then inserted through 
the hole in the rubber stopper, as shown in figure 9(B). 
 
 
 
 
 
 
 
 
 
Figure 9: Integration of the fiber excitation source with the IVIS whole-animal 
imaging system. (A) Both optical systems on the same bench top. (B) The fiber is 
coupled via a test tube stopper placed into the access port of the IVIS system. 
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4.3 Spectral unmixing 
To reduce the effects of tissue autofluorescence and quantify the fluorescence 
signal for each individual fluorophore in both in-vivo and ex-vivo experiments, all whole-
body images were post-processed using spectral unmixing with Living Image Software 
(Caliper Life Sciences). 
Spectral unmixing is a powerful technique in fluorescence imaging to reduce the 
effect of natural tissue auto-fluorescence and separate multiple fluorescence spectra from 
multiple fluorescence probes present in tissue [30]. The spectral unmixing separates image 
data according to spectra from multiple biophotonic internal light sources in an effort to 
isolate one or more spectra of interest. Spectral unmixing obtains multiple images, each 
captured with a combination of different and known excitation and emission wavelength 
bands. The spectral unmixing then uses an iterative solution process to separate spectra 
for the multiple light sources, and provides a spectrum and/or a spatial distribution map 
for at least one of the internal light sources [65]. The basic algorithm for spectral unmixing, 
as well as the different ways to apply that on whole-body images using the Living Image 
software, are explained in the following sections. 
4.3.1 Fundamental algorithm of spectral unmixing 
Linear unmixing is the most common way to process and analyze the images that 
contain a mixed contribution of localized labels. The basic assumption of linear unmixing 
is that the spectral properties of each pixel 𝐷(𝜆) are a linear combination of individual 
fluorophores’ pure spectra 𝑆(𝜆) multiplied by the concentration 𝐶 plus residue 𝐸(𝜆). 
Therefore the linear unmixing equation would be: 
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𝐷(𝜆) = Σ𝐶𝑆(𝜆) + 𝐸(𝜆) (4-1) 
 Equation (3-1) can also be expressed as a matrix form: 
𝐃 = 𝐂𝐒 + 𝐑 (4-2) 
where D is a m×n spectral data matrix (m corresponds to the number of pixels and n 
corresponds to the different wavelengths or spectral bands);  C is a m×k concentration 
profile matrix, where each row represents the combination of the mixed fluorophores at 
that pixel; S is a k×n spectra matrix, in which each row represents the pure spectrum of 
the corresponding fluorescent probe measured at those wavelengths; and R is the m×n 
residual matrix which ideally should be close to the experimental error. Based on equation 
(4-2), D is a linear function of both C and S. In order to calculate the concentration profile 
based on this linear model, several rules should be followed: 1) all the significant 
fluorophores present in the image should be addressed in this mode; 2) the number of 
imaging wavelengths (band-pass filters) should be at least equal to the number of 
fluorophores needed to detect (n ≥ k); and 3) the pure spectrum for each fluorophore S 
should be defined beforehand, either measured individually or selected from a pixel that 
only has one fluorophore. Therefore, concentration profile C can be calculated using the 
below equation [66]: 
𝑒2 = ∥ 𝐃 − 𝐂𝐒 ∥2 (4-3) 
The outputs of this technique are: a) the spectrum of the desired fluorescence probe, and 
b) the spatial distribution map for that fluorescence probe. 
 Spectral unmixing is a useful technique even in the case of a single fluorescent 
probe in an animal. In this case, tissue autofluorescence can reduce the accuracy of the 
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subsequent image processing, therefore separating its spectrum from the desired 
fluorescent probe’s spectrum is necessary [30, 65]. 
 Living Image software provides four spectral unmixing methods to separate the 
spectrum of different fluorescent reporters, as well as tissue autofluorescence, and 
calculate the corresponding contribution of each fluorophore on every pixel of an image. 
4.3.2 Spectral unmixing methods 
 The guided method for spectral unmixing can be used when the location of the 
fluorescent probe is known, and probe signals are just mixed with tissue autofluorescence, 
not overlapped with other probe signals. The guided method is a good way to generate a 
spectral library for probes with known spectra and known locations [67]. 
The library method uses a user-generated spectrum library to analyze an image set. 
All the images that are going to be analyzed by this technique must be acquired using the 
same, or a subset of, the excitation/emission filter pairs of the spectral library. By applying 
this method for spectral unmixing, the software identifies pixels with spectral 
characteristics that match the spectra library [67].  
 Automatic spectral unmixing can be used when the fluorophore’s location is 
unknown. The automatic method uses the pre-defined software’s spectral library to 
analyze the image [67]. 
 Sometimes there is a need to manually analyze the results, especially when the 
automatic spectral unmixing is unable to distinguish different spectra from each other. 
When using manual spectral unmixing, tissue autofluorescence signal should be manually 
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subtracted from the fluorophore’s spectrum, to produce the pure spectrum for the desired 
fluorescent probe [67]. 
 The spectral unmixing results include a signal distribution map of each unmixed 
result and a composite image of all signals, each displayed in a different color. After 
spectral unmixing, the signal intensity for each fluorescent probe can be measured over a 
specific and defined region of interest (ROI).  
4.3.3 Comparison of automatic spectral unmixing with manual spectral unmixing  
 In order to evaluate the different spectral unmixing techniques, a group of five- to 
seven-week old female BALB/C mice were infected with 106 CFU of BCG17 (tdTomato 
expressing BCG strain) or 105 CFU of BCG39 (carry empty plasmid) as a vector control 
by the intratracheal route. 
 In order to apply automatic spectral unmixing using Living Image software, a set 
of images with different emission wavelengths should be loaded. For this specific 
fluorescent reporter (tdTomato expressing BCG strain), the emission wavelengths were 
selected from 580 to 640 nm in 20 nm increments. The excitation source from the IVIS 
was blocked, and the fiber optic illumination source was turned on at 531 nm.  
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By selecting the automatic spectral unmixing from the drop-down menu on the 
“Tool Palette”, the Auto Unmix window appears, including a purple data mask showing 
the region to be included in the analysis. Since the purpose is to detect the bacteria inside 
the lung, the mask can be drawn on a lung area. The specific fluorophore probe which 
needs to be separated from tissue autofluorescence can also be selected from the drop-
down list (figure 10).  
As discussed previously, for automatic spectral unmixing, the software uses its 
pre-defined spectra for each fluorescent probe, as well as tissue autofluorescence (figure 
11). After applying spectral unmixing using this method, the Unmixing window shows the 
analysis results which include unmixed spectra, unmixed images, and a composite of the 
unmixed images (figure 12). In figure 12, the unmixed spectra do not match with the 
expected tdTomato and tissue autofluorescence spectra. This result shows that automatic 
Figure 10: Spectral unmixing window while applying 
automatic spectral unmixing technique using Living Image 
software 
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spectral unmixing technique is unable to separate tissue autofluorescence spectrum from 
the fluorescent probe for in-vivo images. 
In order to separate the fluorescent probe’s spectrum from tissue autofluorescence 
spectrum in in-vivo images, a combination of manual spectral unmixing method with 
Figure 11: Pre-defined spectra in Living Image software for automatic spectral 
unmixing; tdTomato spectrum (left), tissue autofluorescence for mouse tissue (right). 
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library spectral unmixing was used. The first step was to build a library for tissue 
autofluorescence spectrum from vector control animals that do not have any fluorescent 
probes. By selecting the manual spectral unmixing method from the drop-down list, the 
image cube shows a pseudo color image that is a composite of the stack images that have 
been colorized to encode spectral information. By moving the mouse pointer over the 
image cube, the spectrum of a particular location can be observed on the screen. The region 
of interest that represents the signal location was selected (figure 13), and the measured 
signal was saved as the tissue autofluorescence library. 
 
 
Figure 12: Automatic spectral unmixing results for 
tdTomato and tissue autofluorescence. 
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The fluorescent probe spectrum can be obtained from the infected animals with 
tdTomato using the same manual spectral unmixing technique. However, the measured 
signal is an overlap of tissue autofluorescence spectrum and fluorophore’s spectrum. In 
order to correct the overlapping signal, the tissue autofluorescence spectrum was 
subtracted from the overlapped signal using the Living Image software (figure 14). 
 
 
Figure 13: Manual spectral unmixing method to define a library for tissue 
autofluorescence spectrum using Living Image software. 
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After correcting the overlapped spectra, the spectral unmixing results are shown in 
figure 15. The calculated spectra for tdTomato and tissue autofluorescence are close to the 
expected spectra. 
Figure 14: Correction for overlapping 
spectra by subtracting one spectrum 
from another in manual spectral 
unmixing method. 
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4.4 Results 
4.4.1 Comparison of intravital excitation using diffusing fiber and multimode fiber 
A preliminary evaluation and comparison between the excitation efficiency of the 
fiber diffuser excitation source and multimode fiber excitation source was performed. Four 
uninfected mice were imaged first using two intravital excitation sources at tdTomato 
wavelength’s imaging setting. After imaging uninfected animals, the same four mice were 
infected with 106 CFU tdTomato-expressing BCG and imaged 24 hours after infection. 
IVIS acquisition was performed with the excitation filter set to “block” and the emission 
filter set to 580, 600, 620, 640 and 660 nm, as well as “open” for imaging the tdTomato-
expressing bacteria. The open position was used to determine the location of the tip of the 
fiber inside the animal. The exposure time for each wavelength was set to “auto”. Each 
animal was also imaged using IVIS excitation (epi-illumination) as well. Figure 16 shows 
Figure 15: Manual spectral unmixing results following overlapping 
spectra correction. 
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a representative image of tdTomato-expressing BCG infected mice using the diffusing 
fiber excitation source [figure 16 (A)] and multimode fiber excitation source [figure 16 
(B)] for the same fiber output power (~300 μW). Figure 17 shows mean and standard 
deviation for infected groups imaged with the diffusing fiber source and multimode fiber 
excitation source. The results demonstrated that the diffusing fiber excitation source can 
illuminate larger area of tissue, and enhance the level of the detected fluorescence signal 
from the tissue. 
 
 
 
 
 
 
Figure 166: Comparison of excitation efficiency for diffusing fiber 
excitation source (A) and multimode fiber excitation source (B) for the 
same output power. 
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4.4.2 Comparison of intravital excitation source using diffusing fiber and fiber bundle 
Although the excitation efficiency can be improved by adding a diffusing tip at the 
end of the optical fiber, collecting the fluorescence light emitted from the tissue using the 
same fiber used for microendoscopic imaging as feedback is not possible using the current 
diffusing fiber probe. A similar experiment to the diffusing fiber and multimode fiber 
experiment in 4.2.3 has been performed to compare the diffusing fiber and fiber bundle 
excitation efficiency. Figure 18 shows the mean and standard deviation for infected groups 
imaged by diffusing fiber source and fiber bundle. 
In figure 18, the average of detected fluorescence intensity is higher for infected 
groups imaged using the diffuser fiber than the groups imaged using the imaging fiber 
bundle, but they are not significantly different. Although the diffusing fiber generated 
comparable excitation efficiency to the fiber bundle, a single diffusing fiber cannot be 
used for internal detection of the emission light (neither imaging nor sensing), which can 
D iffu s in g  F ib e r M u lt im o d e  F ib e r
6
7
8
9
1 0
F
lu
o
r
e
s
c
e
n
c
e
 (
lo
g
1
0
)
Figure 177: Bar plot of average fluorescence intensity in mice infected by tdTomato-
expressing BCG and imaged using intravital fiber excitation source using two different 
fibers. Error bar shows one standard deviation from the mean. 
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provide feedback on fiber tip position and placement within the airway. In contrast, the 
microendoscope can provide internal imaging feedback to guide placement of the fiber tip 
in contact with the tissue to achieve optimal excitation efficiency. Therefore, the imaging 
fiber bundle microendoscope was used for the experiments described in the remainder of 
this dissertation. 
4.5 Conclusion 
In this chapter, the optical design of the intravital fiber-based microendoscope was 
introduced, and its integration to the whole-animal imaging system was shown. The 
intravital excitation source was tested using different types of optical fibers, and their 
imaging performance was evaluated for each optical fiber. Preliminary experiments on 
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Figure 18: Bar plot of average fluorescence intensity 
in mice infected by tdTomato-expressing BCG and 
imaged using intravital fiber excitation source using 
two different fibers. Error bar shows one standard 
deviation from the mean. 
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infected animals with 106 CFU of BCG17 (tdTomato expressing BCG strain) and 105 CFU 
of BCG39 (empty plasmid) as a negative control revealed that the optical imaging fiber 
bundle is more suitable for the purposes of this study, since it allows microscopic imaging 
feedback for bacterial detection. Different techniques for spectral unmixing were 
compared and their limitations were evaluated. Based on these preliminary experiments, 
the following studies were designed based on using the imaging fiber bundle as the 
illumination source, and applying manual spectral unmixing for image analysis. 
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CHAPTER V 
INTRAVITAL FLUORESCENCE EXCITATION TO ENHANCE THE DETECTION 
SENSITIVITY IN WHOLE-BODY FLUORESCENCE IMAGING OF BACTERIAL 
INFECTION USING RECOMBINANT STRAINS OF BACTERIA 
5.1 Introduction 
Whole-animal optical imaging has found widespread use in the biological 
sciences. Fluorescence-based techniques have been used to study both fixed and live 
biological specimens, allowing for highly selective and specific detection of molecules 
even at low concentrations [68]. While traditional fluorescence microscopy requires the 
sacrifice of multiple animals at discrete time points, whole-animal imaging allows 
researchers to study disease progression or the efficacy of a therapeutic agent more 
precisely and with fewer animals than prior imaging techniques [69]. Whole-animal 
fluorescence imaging is used to study disease pathogenesis, develop novel probes, and 
measure response to new therapies [41]. Fluorescent reporter strategies include delivery 
of fluorescent probes targeted to a specific moiety or transfection of cells with genes 
encoded for a fluorescent protein as an intrinsic reporter probe. 
To record a planar image of an internal fluorescent target in a small animal, whole-
animal imaging systems can be configured either for epi-illumination, with the light source 
on the same side of the tissue as the detector, or trans-illumination, with source and 
detector on opposite sides of the tissue. Although trans-illumination is preferable due to 
superior tissue volume sampling and reduced skin autofluorescence, trans-illumination 
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systems are more complex and expensive than epi-illumination. Fluorescence molecular 
tomography using multiple source and/or detector locations provides enhancements in 
sensitivity and localization of fluorescent targets over planar trans-illumination [32]. 
Simplicity in design, ease of operation, and high throughput has yielded broad use 
of epi-illumination imaging systems, albeit with noteworthy shortcomings. Excitation 
light is generated from a filtered lamp and broadly distributed over the sample stage to 
provide relatively even field illumination. Surface and subsurface fluorescence signal 
emitted from the animal is filtered by high-quality emission filters and captured by a 
sensitive charge-coupled device (CCD) camera. Epi-illumination systems traditionally 
suffer from relatively poor depth sensitivity due to light absorption by tissue [41]. 
Excitation light decreases exponentially with depth; thus, the images are surface-weighted. 
This is particularly the case when using fluorescent reporters that excite with shorter 
wavelengths (<600 nm) where hemoglobin absorption is stronger [17]. Additionally, 
autofluorescence from a wide variety of molecules present in living tissue, particularly the 
skin in epi-illumination mode, generates significant background signal in this portion of 
the spectrum [70]. Increased background limits detection sensitivity, especially when the 
fluorescent target is deep within the animal [71]. Therefore, detected fluorescence signal 
depends on the brightness and excitation wavelength of the selected fluorescent protein, 
the number of fluorescent cells, and the depth and location within the animal. 
Whole-animal imaging has been used to study a wide range of diseases and organ 
systems, including brain cancer [72], neurological degenerative disease [73], 
atherosclerosis [74], myocardial infarction [74, 75], and respiratory infections such as 
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tuberculosis [44]. For many applications, increased detection sensitivity could greatly 
enhance the ability to study pathogenesis in more physiologically relevant conditions. For 
instance, detection of Mtb-expressing tdTomato fluorescent protein has been 
demonstrated in-vivo for subcutaneous infections of 105 CFU [40]. Detection of infections 
in the lung requires even larger numbers of bacteria, but infections such as these are not 
physiologically normal, at least at early time points during infection. Thus, significant 
enhancement of detection sensitivity could improve the ability to study progression of 
respiratory infection from the onset under more relevant conditions. 
Excitation intensities fall off exponentially as light propagates through 
homogeneous tissue; this loss typically plays a dominant role in detection sensitivity in 
whole-animal fluorescence imaging. Delivering the excitation light directly to the target 
area inside of an animal that is placed in a whole-animal imaging system could greatly 
enhance the ability to measure weak fluorescence signal from deep within the animal.  
Fiber-optic based imaging has also become increasingly versatile in recent years 
as fiber components have decreased in size and gained functionality [76]. Flexible fiber-
optic endoscopes, ranging in size of a millimeter up to a centimeter in diameter, have been 
used to image hollow cavity tissues such as the cervix or digestive tract [20, 52, 77-88]. A 
fiber-based microendoscope coupled into a whole-animal imaging system allows for 
excitation light to be delivered inside an animal model. This greatly enhances the intensity 
inside the animal, as the optical path length between the source and expected location of 
the fluorophore is minimized. In addition, such a system allows for multi-scale imaging, 
where microscopic imaging is achieved simultaneously with macroscopic whole-animal 
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images. Although the use of fiber optic technology can be applied to a variety of 
biomedical applications where tissue is accessible by a thin optical fiber, the target 
application for this study is TB, a major public health problem worldwide with a high 
prevalence in the developing world, where it is the leading cause of death. 
TB, caused by Mtb, remains a major global health problem, infecting one-third of 
the world’s population [1]. The slow growth rate of Mtb limits progress toward 
understanding tuberculosis including diagnosis of infections and evaluation of therapeutic 
efficacy. There is a growing need for more accurate and rapid diagnostic techniques in 
order to improve the sensitivity and specificity of the traditional methods for TB detection. 
A noninvasive biophotonic imaging technique to monitor bacterial dynamics over time 
with high sensitivity would accelerate pre-clinical evaluation of novel vaccines and 
therapeutic agents [18]. To significantly enhance detection sensitivity of fluorescent 
mycobacteria in the mouse lung, we present the integration of an optical fiber into a whole-
animal imaging system for intravital excitation of a fluorescent target deep within an 
animal. 
5.2 Methods 
5.2.1 Bacterial strains and growth conditions 
Mycobacterium bovis BCG is not virulent in humans and is used as a model for 
tuberculosis in this study, since it is closely related to virulent strains. BCG is an attenuated 
form of live bovine tuberculosis bacillus and routinely used as a vaccine for TB. However, 
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BCG retains the ability to infect and persist within mammalian tissue, similar to 
pathogenic mycobacteria [89]. Two BCG strains, BCG17 (fluorescent protein tdTomato-
expressing BCG strain) and BCG39 (BCG strain carrying the same plasmid without 
tdTomato), were used. Construction of these strains is detailed in [40, 44, 90]. BCG strains 
were grown in 7H9 broth (Difco, Detroit, MI) supplemented with 0.5% glycerol, 10% 
OADC (oleic acid dextrose complex without catalase), and 0.05% Tween 80 (M-OADC-
TW broth), or on Middlebrook 7H9 (BD, Franklin Lakes, NJ) supplemented with 10% 
OADC and 15 g/L Bacto agar (M-OADC agar), or on 7H11 selective media (BD). 
tdTomato was selected as the fluorescent protein for tuberculosis during infection 
in mice for reasons described in [91] including its superior quantum yield as compared to 
the enhanced form of green fluorescent protein (EGFP) [92] and its long emission tail, 
going out to 700 nm, which makes this protein more suitable for in-vivo imaging [17]. 
Also, tdTomato has good photostability, which makes it stable throughout imaging with 
minimal photobleaching [17, 93, 94]. In addition, previous work by Y. Kong et al. 
demonstrated superior detection limits with tdTomato labeled BCG as opposed to BCG 
expressing EGFP [40]. Fluorescent systems in microscopy, pathology, and protein 
analyses are widely used for bacteria and other infectious agents [95-100]. Intravital 
excitation for whole-animal imaging enhances the potential use of current fluorescent 
reporters widely used in pre-clinical imaging studies. 
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5.2.2 Animal infections 
All animal experiments in this study were approved by Texas A&M University 
Institutional Animal Care and Use Committee under animal use protocol number 2015-
0222. Five- to seven-week old female BALB/C mice were used in all experiments. Mice 
were allowed to acclimate to the Biosafety Level 2 (BSL2) facilities for a week and fed 
AIN-93G diet (Harlan Teklad, Indianapolis, IN; TD.94045), a purified chlorophyll-free 
diet to reduce background autofluorescence [28, 29, 101, 102], with ad libitum access to 
tap water. Total 42 mice were randomly grouped with six mice in a group. Groups of mice 
were infected by intratracheal instillation of 101-106 CFU BCG17 (tdTomato-expressing 
BCG strain) or 105 CFU BCG39 (same plasmid without tdTomato) as a vector control. 
The detailed procedure of infection was described previously [22]. After 24 hours of 
infection, whole-body images were acquired using epi-illumination and intravital 
microendoscope illumination. Mice were sacrificed by injection of 100 µL Fatal-Plus 
Solution (Vortech Pharmaceuticals Ltd, Dearborn, MI, NDC; 0298-9373-68), and lungs 
were removed for ex-vivo imaging. The excised lung tissues were homogenized and 10-
fold serial dilutions of lung homogenates were plated on 7H11 selective media to 
enumerate bacterial CFU in the lung. 
 
5.2.3 Fluorescence microendoscope 
Figure 19 illustrates the fluorescence microendoscope that was constructed for 
bacterial detection. The basic design is similar to the system previously reported for the 
use in bacterial imaging in situ [91]. A light emitting diode (Thorlabs, Newton, NJ; 
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M530L2) centered at 530 nm with a 31 nm bandwidth is used for fluorescence excitation. 
This wavelength was selected for excitation of tdTomato fluorescent protein (Ex: 554/Em: 
581). Light from the diode is collimated, filtered with an excitation filter (Semrock, 
Rochester, NY; FF01-531/40) and dichroic mirror (Semrock; FF562-Di), and launched 
into a fiber bundle (Fujikura, Dudley, MA; FIGH-10-500N) by a 10x objective lens 
(Thorlabs; RMS10X). The 0.66 mm outer diameter fiber bundle consists of 10,000 
individual optical fibers. A 3 µm core-to-core spacing limits the resolution, and the 450 
µm active area determines the field of view of the microendoscope [103]. Excitation light 
is guided by the fiber bundle to its distal tip, which can then be inserted into an orifice of 
an animal model and placed in contact with internal organs. The typical output power from 
the fiber bundle was measured to be 300 µW. Fluorescence emission incident on the fiber 
bundle and within its angle of collection is relayed by the bundle, filtered by a longpass 
emission filter (Semrock; FF01-593/LP-25), and then imaged onto a scientific grade 1.45 
megapixel CCD camera (QImaging, Surrey, BC, Canada; EXi Blue) with 6.45 µm x 6.45 
µm pixel size. 
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5.2.4 Integration of microendoscope with whole-animal imager 
Multi-scale imaging of bacterial infections was achieved by integrating the 
microendoscope into a whole-animal optical imager (PerkinElmer, Waltham, MA; IVIS 
Lumina II). The fiber bundle was inserted into the whole-animal enclosure through an 
access port located on the side of the system, shown in Figure 20. To prevent any external 
light from entering the system, a 0.5 mm hole was drilled into a rubber stopper (VWR, 
Radnor, PA; 59580-069) which was then inserted into the access port opening. The fiber 
bundle was then inserted through the hole in the rubber stopper, as shown in Figure 20 
(B). 
 
 
 
Figure 19: Illustration of the microendoscope system. 
LED: light emitting diode; L1: collimating lens; F1: 
excitation filter; D: dichroic beamsplitter; Obj: 
Microscope objective; F2: Emission filter; L2: 
focusing lens; FB: fiber bundle [124]. 
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5.2.5 In-vivo animal whole-body imaging 
The detection of respiratory infections of BCG was used to evaluate the 
enhancement of fluorescence signal in whole-animal imaging using an intravital excitation 
source. All imaging was performed in a BSL2 laboratory in accordance with local safety 
regulations. Mouse fur was not removed for imaging; previous work demonstrated 
accurate localization and detection of tdTomato labeled BCG strains in mice that had fur 
[40, 44, 90]. A 22G x 1” intratracheal catheter (TERUMO Medical, Somerset, NJ; 
SURFLO® I.V. SR-OX2225CA) was inserted into the trachea of the mouse anesthetized 
with ketamine (100 mg/kg) (Henry Schein, Melville, NY) and xylazine (10 mg/kg) (Alfa 
Aesar, Haverhill, MA) mixture [104]. The mice were then placed on the IVIS stage in a 
ventral position, and the paws were loosely secured to the stage with tape. The lower 
abdomen was covered using a black cloth to block background fluorescence signal 
generated from gastrointestinal tract and kidney. The fiber bundle was inserted into the 
Figure 20: (A) Integration of the intravital fiber 
excitation source into the IVIS whole-animal imaging 
system. (B) The fiber is coupled via a test tube stopper 
placed into the access port of the IVIS system [124]. 
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intratracheal catheter until it was in proximity with the tracheal wall and fluorescent signal 
could be observed using the microendoscope. Insertion of the fiber into the mouse airway 
was limited to the initial bifurcation of the lungs, as guiding the bundle beyond this point 
is difficult in the small space of a mouse lung. The fiber bundle was marked to ensure 
comparable insertion distance among animals and to help guide the fiber insertion in the 
vector control animals. The fiber bundle was also secured to the stage to ensure constant 
positioning of the fiber during imaging. The distal section of the fiber bundle, which comes 
in contact with the infected tissue, was thoroughly decontaminated with 70% isopropyl 
rubbing alcohol (Vi-Jon, Smyrna, TN) after imaging each animal to avoid cross-
contamination. 
Animal whole-body imaging was acquired by IVIS Lumina II using two different 
excitation sources – intravital and epi-illumination. First, the microendoscope was used 
for intravital excitation with the IVIS excitation filter wheel set to ‘block’ the IVIS 
illumination. Fluorescence images were collected with the IVIS emission filter set to 580, 
600, 620, and 640 nm center wavelengths, as well as the “open” setting, which was used 
to visualize the illumination profile in the animal. The corresponding microscopic image 
of the lung tissue was also collected using the microendoscope CCD. Subsequently, the 
microendoscope source was switched off, and the IVIS excitation filter was set first to 535 
nm for excitation of tdTomato fluorescence and then to 465 nm for autofluorescence. Epi-
illumination images were captured using the same IVIS emission filter center wavelengths 
as for intravital excitation. Following whole-body imaging, the lungs were excised and 
imaged using epi-illumination with the same excitation and emission filter sets as whole-
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body imaging. For all images, IVIS acquisition settings were as follows: f/stop: 2, Binning: 
8, Automatic exposure. 
5.2.6 Image analysis 
Manual spectral unmixing was performed using PerkinElmer Living Image 
software (version 4.3.1) in order to reduce the effects of tissue autofluorescence 
background and to quantify the tdTomato fluorescence signal detected by whole-body 
imaging with intravital or epi-illumination. For each animal, the spectrum for tdTomato 
fluorescence exiting the body from the lungs was estimated by subtracting the spectrum 
containing both tdTomato and tissue autofluorescence obtained from the mouse infected 
with tdTomato-expressing BCG strain from the tissue autofluorescence spectrum obtained 
from the vector control animal. Following spectral unmixing, fluorescence radiance was 
quantified over a pre-defined region of interest targeting the lungs. 
5.2.7 Statistical analysis 
Statistical analysis was performed using GraphPad Prism software (Version 6). A 
nonparametric statistical method, Kruskal-Wallis for multiple comparisons with the 
Bonferroni posttest (Dunn’s procedure), was used to determine statistical significance 
compared to the vector control [105-107]. P < 0.05 was considered significant. To test the 
correlation of CFU and fluorescence signals, a Pearson correlation test was performed. 
Linear regression analysis was also applied to determine the relationship between CFU 
and fluorescence signals. 
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5.3 Results and discussion 
While providing the ability to acquire both macroscopic and microscopic images 
of bacterial infections from the same animal, the combination of the two optical systems 
alleviates some of the individual limitations of each. First, the IVIS CCD can be used to 
localize and track the fiber bundle position inside the animal, allowing for proper 
positioning of the distal tip prior to data collection. More sophisticated whole-animal 
imaging systems with optical tomography or x-ray imaging capabilities could allow more 
accurate determination of the fiber tip location. Additionally, the microendoscope source 
can serve as an intravital excitation source for the whole-animal fluorescence imager. By 
delivering the excitation light internally, the attenuation of the excitation light by tissue 
structures such as the chest wall is greatly decreased, allowing for an increase in the 
delivery of excitation light inside the region of interest. Prior to in-vivo imaging using 
intravital excitation, we evaluated intravital excitation illumination in the lung of mouse. 
Figure 21 (A) shows a mouse with its chest wall opened after sacrifice, exposing the lungs 
and demonstrating the origin of the intravital excitation light within the animal’s body. 
Figure 21 (B) depicts a typical microendoscope image obtained from the fiber bundle. The 
fiber bundle pattern is superimposed on the fluorescence signal acquired from the tip of 
the microendoscope.  
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5.3.1 In-vivo whole-body imaging using intravital fiber excitation 
Representative whole-body images acquired using the intravital fiber excitation 
are shown in Figure 22 (A) for mice infected with 101 to 106 CFU BCG17, as well as a 
representative image of a 105 CFU infection of BCG vector control. Images with signal 
levels close to the mean value for the group were considered representative. All images 
were acquired using identical imaging parameters. Fluorescence images have been scaled 
such that no signal was present in the vector control for better comparison. Fluorescence 
signal was quantified by measuring fluorescence intensity over the chest region of interest. 
Detected fluorescence signal increased with bacterial CFU and minimal signal was 
observed in the vector control group (Figure 22). We found that intravital excitation could 
be used to detect pulmonary infection levels of 103 CFU with a significant difference from 
Figure 21: Intravital excitation illumination via microendoscope in the mouse airway. 
(A) Image of sacrificed mouse with open chest wall and intravital illumination 
showing the proximal placement of the fiber bundle in the trachea. (B) Example 
fiber bundle image of BCG17 bacterial fluorescence collected with the 
microendoscope CCD. The microendoscope image is used to guide placement of 
the intravital source in contact with tissue prior to IVIS imaging [124]. 
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the vector control (P < 0.01). A linear regression fit was applied to assess correlation of 
the average fluorescence for each group with average CFU in lung homogenates. 
Fluorescence signal correlates well with bacterial CFU, with R2= 0.945 (P = 0.0011), 
demonstrating the ability to quantify bacterial CFU using intravital excitation.  
 
Figure 22: Intravital fluorescence excitation of tdTomato expressing BCG after 
intratracheal pulmonary infection of mice. (A) Representative whole-body images 
acquired using integrated microendoscope (intravital fiber excitation) at 24 hr post-
infection with 101-106 colony forming units (CFU) BCG17 and 105 CFU BCG39. (B) 
Scatter plot of fluorescence signal for each animal imaged as compared to actual CFU in 
lung homogenates from the same mouse. (C) Correlation of fluorescent signal to number 
of bacterial CFU in lung homogenates. Error bars represent the standard error for each 
sample group. **p‐value < 0.01, ***p‐value < 0.001: significantly different from 
fluorescence of vector control group (horizontal dashed line in C) calculated by non-
parametric Kruskal-Wallis test with the Bonferroni posttest. All images and measurements 
represent tdTomato contribution to signal after spectral unmixing [124]. 
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Representative microscopic images acquired using the microendoscope CCD 
camera are shown in Figure 23 for the mice infected with different concentrations of 
BCG17 (101-106 CFU), as well as a representative image of the 105 CFU vector control. 
Fluorescence signal captured by the microendoscope increased with bacterial numbers, 
particularly for mice with >104 CFU in lung homogenates. However, microendoscopic 
fluorescence is dependent on positioning of the intratracheal catheter and microendoscope 
fiber tip within the airway. Microendoscope images are primarily used to ensure fiber tip 
contact with tissue, which results in enhanced intravital excitation for whole-animal 
imaging. Bacteria are unlikely to be located precisely at the surface of the microendoscope 
following 24 hr incubation; therefore, spatial variation within a single microendoscope 
image may be attributed to scattering of fluorescence emission by tissue and mucous 
structure at the surface of the microendoscope tip. 
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5.3.2 In-vivo whole-body imaging using IVIS epi-illumination 
To provide a comparison between whole animal imaging using intravital excitation 
and standard epi-illumination, images were acquired using the IVIS epi-illumination 
excitation and detection. Representative images for infections of 101 to 106 CFU BCG17 
are shown in Figure 24 (A). A representative image of the 105 CFU vector control is shown 
in Figure 24 (A). Images with signal levels close to the mean value for the group were 
considered representative. All images were acquired using identical imaging parameters. 
Figure 23: In-vivo microendoscope images provide feedback for positioning the 
intravital excitation source and can allow a qualitative evaluation of bacterial loads 
in the lungs. Representative in-vivo fiber microendoscopy images of infected mice 
lungs, 24 hr post-infection with 101-106 colony forming units (CFU) BCG17 
(tdTomato expressing BCG strain) and 105 CFU BCG39 (BCG containing the same 
vector that does not express tdTomato (Vector)) [124]. 
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Epi-illumination in whole-animal imaging is unable to differentiate between vector control 
group and infected groups with any statistical significance, even for the highest 
inoculation dose (P=0.054). Although the fluorescence intensity for BCG17 infected 
groups is not significantly higher than the vector group, even after spectral unmixing, the 
detected signal correlates well with CFU numbers. Comparing signal to background levels 
for epi-illumination (Figure 24 (B)) and intravital illumination (Figure 24 (C)), shows that 
signal to background level for epi-illumination is less than 2× for all infections; whereas, 
signal to background level in intravital excitation ranges from 10× to more than 100× with 
increasing bacterial load.  
5.3.3 Ex-vivo lung tissue imaging 
To avoid skin autofluorescence and improve penetration of epi-illumination 
excitation light to the bacteria within the lung, infected lungs were excised and imaged 
using IVIS epi-illumination. The same acquisition filter settings and manual spectral 
unmixing method were used as whole-body imaging using IVIS epi-illumination. As 
shown in figure 25, fluorescence signal correlates with increased bacterial numbers as 
quantified by CFU in lung homogenates (R2= 0.851, P=0.0088). However, detection of 
infection was significant only in the group infected with 106 CFU BCG17 as compared to 
the vector control group (P = 0.0030). Epi-illumination imaging of lungs ex-vivo enhances 
signal to background compared to in-vivo by the same technique. Internal excitation in 
excised lungs is not straightforward due to the complexity and small size of the trachea 
and the potential for collapse of the lungs upon penetration of pleura; however, intravital 
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excitation combined with whole-animal imaging was found to be more sensitive than ex-
vivo epi-illumination. 
 
 
 
 
 
 
Figure 24: In-vivo whole-body imaging of infected mice using IVIS epi-
illumination. (A) Representative images of bacterial infection at 24 hr 
post-infection with 101 to 106 colony forming units (CFU) BCG17 
(tdTomato expressing BCG strain) and 105 CFU BCG39 (BCG containing 
the same vector that does not express tdTomato (Vector)). (B) Correlation 
of fluorescence signal in mouse whole-body images versus CFU in lung 
homogenates from the same animal. Error bars represent the standard error 
for each sample group. Horizontal dashed line in (B) represents the 
average signal for the vector control group. All images and measurements 
represent tdTomato contribution to signal after spectral unmixing [124]. 
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Figure 25: Epi-illumination images of excised mouse lungs 
infected with tdTomato-expressing BCG or BCG with vector 
backbone. (A) Representative images of excised lungs infected 
with 101 to 106 colony forming units (CFU) BCG17 (tdTomato 
expressing BCG strain) and 105 CFU BCG39 (BCG containing 
the same vector that does not express tdTomato (Vector)). (B) 
Correlation of fluorescence signal in ex-vivo images of lungs 
and CFU in lung homogenates from the same animal. Error 
bars represent the standard error for each sample group. ** p‐
value < 0.01: significantly different from fluorescence of vector 
control group (horizontal dashed line in B) calculated by non-
parametric Kruskal-Wallis test with the Bonferroni posttest. 
All images and measurements represent tdTomato contribution 
to signal after spectral unmixing [124]. 
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5.4 Conclusions 
We have developed a novel system to sensitively detect bacterial infection in living 
animals. By integrating a fiber-based microendoscope into the IVIS whole-animal 
imaging system, we enabled intravital excitation of fluorescent bacteria within the mouse 
lung. Using intravital excitation and whole-animal fluorescence imaging, we decreased 
the level of detection of tdTomato-expressing bacteria in the lungs of living mice to 103 
CFU; whereas, epi-illumination for whole-animal imaging was unable to detect infections 
with as many as 106 CFU.  
Intravital excitation circumvents the expected absorption of light by the tissue 
present in the chest wall of mammals. Furthermore, autofluorescence is significantly 
reduced by illuminating from within the body, similar to the autofluorescence reduction 
observed with transillumination using whole-body imaging systems. Transillumination, 
where the light source and detector are located on opposite sides of the animal, provides 
enhanced detection sensitivity as compared to epi-illumination, most likely due to 
reflected autofluorescence. As excitation and emission light must be transmitted through 
the animal to the fluorescent source being detected, these systems inherently are impacted 
by characteristics of the tissue deep inside the animal and are less affected by the depth of 
the fluorophore. Therefore, transillumination is more ideally suited for detection of 
fluorescence from the respiratory system. Intravital excitation has the potential to be more 
sensitive yet, due to the more direct delivery of excitation light, which is shorter in 
wavelength than emission light and more dramatically impacted by depth. 
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While the fiber microendoscope used for these experiments employed a fiber 
bundle to deliver excitation light to the lungs, a simple large core, multimode fiber could 
be used in its place. This would allow for additional increases in excitation power delivery. 
In addition, the system could be further miniaturized and designed to operate solely on 
battery power. This would allow for imaging inside whole-animal imaging systems that 
might lack an access port, though this was not necessary for our current system, since the 
IVIS Lumina II has an access port. 
Insertion of the intratracheal catheter and microendoscope into the airway must be 
performed with great care and caution to avoid tissue damage or animal suffering. There 
was no evidence of tissue damage due to optical fiber placement. The insertion of an object 
into the airway has the potential to disturb or artificially spread the infection within the 
airway. To avoid contamination between animals, the tip of the optical fiber is carefully 
decontaminated with isopropyl alcohol, after imaging each animal. 
A greater understanding of the illumination profile generated within the body by 
the internal excitation is needed to better understand the physical limitations of intravital 
excitation. In this study, the fiber bundle excitation source is placed at the tracheal 
bifurcation and directed towards the base of the lungs. After 24 hours post-infection 
bacteria may not be present in the trachea or bronchi. Using intravital excitation in mice 
and other small animals, the highly scattering nature of the lung tissue is exploited to 
illuminate the entire chest cavity. Excitation light from the intravital source is visible 
through the chest wall. 
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Imaging data presented here was acquired 24 hours after bacterial infection. 
Intravital excitation should be assessed to monitor dynamics of bacterial load over longer 
time periods. Typically, a granuloma forms at approximately five weeks or later post-
infection. The impact of the immune response or granuloma formation on intravital 
excitation of bacteria within a granuloma would be an interesting avenue of further study, 
as well as different aspects of pathology that might arise during later stages of disease 
[108-111].  
Beyond the application of this technology to detection of mycobacteria in the 
lungs, intravital excitation may be applied to enhance sensitivity of fluorescent marker 
detection in other deep tissues, such as within the gastrointestinal tract. The fiber bundle 
microendoscope or optical fiber excitation source can be passed through other natural 
orifices or inserted into the body through a needle in a minimally invasive procedure. We 
envision a number of additional applications for this technology that could allow 
improvements in imaging sensitivity of not only infectious diseases, but also other 
diseases of significant importance that can be evaluated with optical imaging. 
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CHAPTER VI 
IMAGING TUBERCULOSIS WITH ENDOGENOUS Β-LACTAMASE 
6.1 Introduction 
Diagnosis of tuberculosis using standard methods that take weeks to obtain results 
is a major challenge to control this worldwide disease. Similarly, this bacterial culture 
timeline limits tuberculosis research using animal models, where data analysis is 
dependent upon counting of CFU [44]. Although recombinant reporter strains of 
mycobacteria such as tdTomaro-expressing BCG bacteria have been established to detect 
mycobacteria in animal experiments using different imaging techniques (fluorescence, 
luminescence [112-116], single photon emission computed tomography (SPECT) [117, 
118]), these techniques need specific laboratory strains or cannot be used for specific 
detection of pulmonary TB directly in-vivo. Expression of foreign genes in recombinant 
reporter strains can alter bacterial fitness in unexpected ways, especially when expressed 
from plasmids [119-121]. Therefore, the development of a non-invasive technique that 
allows detection of Mtb directly without expression of foreign genes would facilitate TB 
research with clinical strains, and would have a great impact on developing TB 
therapeutics and vaccines. The sensitive detection of nonrecombinant strains can 
ultimately be applied to patients’ sputum and other diagnostic samples, as well as patients 
themselves. 
A reporter enzyme fluorescence (REF) system, using a custom synthesized near-
infrared (NIR) β-lactamase (BlaC)-specific fluorogenic substrate, CNIR5, has been 
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developed for real-time imaging of pulmonary infections and quantification of Mtb 
infection in-vivo. This technology has made a significant breakthrough in the whole 
animal imaging threshold of detection of bacteria in the lungs of mice, down to ~104 CFU, 
a 100-fold improvement over recombinant strains [44]. However, improvement of 
detection sensitivity is needed for clinical diagnosis of early stage infection at greater 
tissue depth. In order to improve detection sensitivity, we have integrated a fiber-based 
microendoscpe into a whole-animal imaging system to transmit the excitation light from 
the fiber bundle to the fluorescent target and measure fluorescence using a BlaC-specific 
REF substrate in the mouse lung.  
 
6.1.2 Imaging with reporter enzyme fluorescence (REF) 
Figure 26 (A) shows the expression of β-lactamase enzyme in three common Mtb 
strains including H37Rv, CDC1551, and Erdman, and H37Rv blaCm strain with a 
mutation in the blaC gene. As expected, all Mtb strains produce a measurable membrane-
localized β-lactamase within 2 hour to 20 hour, as measured by the change in fluorescence 
of Fluorocillin Green (Ex/Em: 485/530 nm), in the presence of 107 bacteria. The 
significant difference between the fluorescence signal of the mutant H37Rv blaCm and 
other Mtb strains indicates that BlaC is responsible for the majority of β-lactamase activity 
in Mtb. Figure 26 (B) shows that Mtb BlaC is primarily surface-localized, makes it an 
ideal candidate for Mtb detection, since substrates would not need to traverse the highly 
selective mycobacterial cell wall [44]. 
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Reporter enzyme fluorescence (REF) utilizes β-lactamase (BlaC) enzyme, along 
with a custom designed fluorogenic substrates. The substrate is composed of a 
fluorochrome and a quencher that are connected by a β-lactam ring. The custom substrates 
for REF also carry acetylated D-glucosamine connected to the carboxylate of cysteine 
through γ-amino-butyric acid producing a charged molecule, which facilitates uptake into 
eukaryotic cells [122]. Once this substrate is within cells, β-lactamase secreted by 
intracellular bacteria cleaves the β-lactam ring. Once the β-lactam ring is hydrolyzed by 
β-lactamase, the fluorochrome moiety is released from the quencher and generates a near 
infrared fluorescent molecule [123]. This system does not utilize recombinant strains, 
which has a significant advantage over reporter strategies, since it is unlikely to have 
unexpected impacts on virulence [119-121]. Figure 27 depicts the REF approach to 
imaging bacterial infections. 
 
 
Figure 26: Expression of β-lactamase in different strains of Mtb 
produce a membrane-localized β-lactamase [45] 
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The extremely high sensitivity of REF in whole-animal imaging is most likely due 
to the catalytic nature of the reporter (BlaC) and the ability of cleaved, fluorescent products 
to build up in the host cell. The resulting fluorescence characteristics would be similar to 
the characteristic of the flourogenic dye used to make the custom substrate [123]. To detect 
Mtb using BlaC, several NIR substrates have been developed with a long wavelength 
fluorescent signal when cleaved (figure 28 (A)), making them good candidates for use in 
Figure 27: (A) Depiction of REF in Mtb. The substrate that is quenched becomes 
fluorescent upon cleavage by BlaC, an enzyme located on the surface of Mtb, 
which prevents the need for the substrate to cross the bacterial cell wall. (B) 
Structure of the first generation substrate CNIR5 that uses Cy5.5 as the fluorescent 
dye. (C) Mechanism thought to be involved in amplification of REF signal. Signal 
builds up in the host cell due to the cleaved, fluorescent dye binding to molecules in 
the host cell. Fluorescent signal can reach very high levels at the site of infection by 
building up in the host cell [45]. 
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in-vivo animal imaging, because of their ability to penetrate efficiently in animal tissue. 
All these substrates show little fluorescence signal before their BlaC cleavage and increase 
in maximal emission after cleavage (figure 28 (B)). Incubation of each of these probes 
with Mtb resulted in an increase in fluorescence signal (figure 29) [44].  
 
 
 
Figure 298: (A) Structure of CNIR substrates. (B) Fluorescence emission spectra of each 
CNIR substrates before and after BlaC cleavage [45] 
Figure 289: Kinetics of CNIR substrates 
incorporation into Mtb and Mtb blaC mutant (blaCm) 
[45] 
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The substrate CNIR5 has been used for detection and quantification of Mtb in-
vitro and in-vivo, since it shows an improved increase in fluorescence signal after 
incorporation into Mtb. The in-vitro results show a good correlation between bacterial 
CFU numbers and level of fluorescence signal for bacterial range of 102 to 106 CFU (figure 
30 (A)). Real-time analysis of Mtb in living mice using CNIR substrates shows that 
CNIR5 could detect 106 bacteria, however the other CNIR substrates could detect 107 
CFU. The highest fluorescence signal was observed at 48 hour post-administration of 
CNIR5, followed by CNIR10, CNIR4, and CNIR9 for animals infected with Mtb and 
closely related vaccine BCG (figure 30 (B-C)). The charged nature of Cy5.5 causes it to 
bind to lipids or proteins present in the host cell and be retained for extended periods of 
time, which can be as long as 72 hour post-administration of the substrate [44]. 
In this study, we used the intravital fiber optic fluorescence microendoscope 
integrated into a whole-animal imaging system for tuberculosis detection in-vivo using a 
NIR BlaC-specific fluorogenic substrate, CNIR800. We demonstrated that integration of 
these optical imaging technologies with BlaC-specific fluorescent reporter probes can 
enable sensitive detection of bacteria in lungs of living animals. This technology can also 
improve the sensitivity of whole-animal optical imaging to enable study of early stage 
bacterial infection, evaluation of therapeutic efficacy, and development of preventative 
treatments. 
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6.2 Methods 
6.2.1 Animal infection 
Mice were randomly grouped in six groups of four mice per group. The mice were 
anesthetized and infected with 10-106 CFU of M. bovis BCG strain by intratracheal 
instillation. M. bovis BCG strain was used in this study as a safety precaution because it 
is closely related to M. tuberculosis but not virulent in humans [89]. A detailed protocol 
for the method of infection was described previously [22]. 24 hours after inoculation, the 
A 
E 
Figure 30: (A) Correlation of fluorescence signal Mtb bacterial CFU numbers in the 
presence of CNIR5 for 24 hour in-vitro. (B) Inoculation sites for different CFU numbers in 
in-vivo experiments along with the position of the reference measurement (R). (C) 
Comparison of the fluorescence signal over time for each CNIR substrate for 108 Mtb and 
(D) BCG. (E) Whole-animal imaging of mice infected with Mtb and administrated CNIR 
substrates at 48 hour post-infection and post-administration [45]. 
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mice were imaged using the whole-body imaging system with intravital excitation. 
Following imaging, the lungs were excised, homogenized, and 10-fold serial dilutions of 
lung homogenates were plated on 7H11 selective media for culturing and CFU counting. 
Animal use protocols were approved by the Texas A&M University Institutional 
Animal Care and Use Committee. Five- to seven-week old female BALB/C mice were 
used in this study. Mice were fed alfalfa-free AIN-93G diet with ad libitum access to 
water. A mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) was used for 
anesthesia. 
6.2.1 Reporter enzyme fluorescence technology and substrate CNIR800 
The CNIR800 substrate consists of IRDye 800CW fluorescent dye linked to a 
quencher (IRDye QC-1) at the distal end through a lactam ring, providing a fluorescence 
resonance energy transfer (FRET) quenching effect (Figure 31) [123]. In the absence of 
BlaC (no mycobacteria), the substrate is quenched and produces minimal fluorescence. 
BlaC cleavage of the lactam ring releases the quencher from CNIR800, significantly 
increasing fluorescence of the IRDye. Cleaved CNIR800 displays maximal signal at an 
emission wavelength of 795 nm with 745 nm peak excitation. The CNIR800 REF substrate 
(20 μM, 2.5 μl/g of weight) was administered intratracheally at 24 hours post-infection. 
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6.2.2 Whole-body fluorescence imaging system with intravital excitation 
Figure 32 shows the integrated whole-body imaging system with intravital 
excitation used in this study, previously described in detail [124]. The fiber-based 
microendoscope image provides real-time feedback for guidance of placement of the fiber 
bundle tip within the airway. In tandem, the microendoscope excitation within the airway 
serves as the intravital light source for whole-body imaging with the IVIS illumination 
blocked. 
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Figure 31: Schematic representation of the reporter enzyme 
fluorescence (REF). The β-lactamase enzyme naturally and 
constitutively expressed in Mycobacterium tuberculosis is 
used to cleave the lactam ring, releasing the FRET quencher 
and allowing recovery of the IRDye 800CW fluorescence 
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The 10,000-fiber bundle (FIGH-10-500N, Fujikura) is routed through an access 
port into the whole-body imaging system (IVIS Lumina II, PerkinElmer), enabling 
insertion into the trachea of the anesthetized mouse through a 22G x 1” catheter 
(SURFLO® I.V. SR-OX2225CA, TERUMO Medical). The excitation pathway of the 
microendoscope consists of a 730 nm laser diode (HL7302MG, Thorlabs), excitation filter 
with 750 nm cut-off wavelength (FES0750, Thorlabs), and 757 nm dichroic mirror 
(FF757-Di01, Semrock) targeting fluorescence excitation of the CNIR800 REF probe. A 
Infection and REF 
Substrate Administration 
REF Substrate Cleavage 
by BCG 
Intravital Excitation for 
Whole-Body Imaging 
M. bovis BCG 
CNIR800 Substrate 
Cleaved CNIR800 
Fiber Optic Excitation 
Figure 32: Whole-body imaging of REF fluorescence with intravital excitation in the 
airway of live mice. 24 hours after BCG infection via intratracheal instillation, CNIR800 
REF substrate is administered through an intratracheal catheter. After a time period to 
allow CNIR800 cleavage, mice are placed in the whole-body imaging system and the 
microendoscope is inserted into the airway for intravital excitation and whole-body 
imaging. 
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10× objective lens (RMS10X, Thorlabs) couples the illumination and imaging system to 
the fiber bundle. A 776 nm emission filter (FF01-776-LP, Semrock) passes CNIR800 
fluorescence to a 1.45 megapixel CCD camera (EXi Blue, QImaging). The 
microendoscope fiber bundle has 0.66 mm outer diameter, 3 µm core-to-core spacing, and 
450 µm field of view [91]. Output power from the fiber bundle was measured to be 1.2 
mW.  
 
6.2.3 In-vivo animal whole-body imaging using REF technology 
Whole-body images of mice were acquired using both intravital fiber excitation 
and IVIS epi-illumination at various time points post-administration of CNIR800. After 
whole-body imaging, animals were sacrificed and lung homogenates were plated for CFU 
counting. To collect images with intravital fiber excitation, a catheter was inserted into the 
trachea of the animal, and the animal was placed on the IVIS stage in the ventral or dorsal 
position. The lower torso of the mouse was covered with a black cloth to block background 
fluorescence of the gastrointestinal tract and kidney. The fiber bundle was fed into the 
catheter until it was in contact with the airway wall. The fiber position was guided and 
confirmed with the image on the CCD camera of the microendoscope. The fiber bundle 
was then marked at the mouth to ensure comparable insertion distance among animals and 
secured to the stage to prevent movement during stage height adjustment for imaging.  
The excitation light source from the IVIS system was blocked, and IVIS 
fluorescence emission filters were selected to collect CNIR800 signal at20-nm increments 
from 760 to 840 nm using the IVIS camera. After imaging with intravital excitation, epi-
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illumination images of the same animal with the IVIS imaging system excitation source 
were collected for comparison. Epi-illumination excitation filters of 675 nm and 745 nm 
were used for background tissue autofluorescence and CNIR800, respectively. The same 
IVIS emission filter settings were used as the intravital fiber excitation configuration. Each 
acquisition was taken with an f-stop of 2, medium binning, and automatic exposure 
settings.  
Manual spectral unmixing was performed using PerkinElmer Living Image 
software (version 4.3.1) to reduce tissue autofluorescence background and quantify the 
REF signal detected by whole-body imaging with intravital or epi-illumination. Following 
spectral unmixing, fluorescence radiance was quantified over a pre-defined region of 
interest targeting the lungs. 
Statistical analyses were performed using GraphPad Prism software (Version 6). 
Student’s two-tailed t-test was used to determine statistical significance compared to the 
control; P < 0.05 was considered significant. Pearson correlation was used to test the 
correlation of CFU and fluorescence signals. The relationship between CFU and 
fluorescence signal was determined using a linear regression analysis. 
 
6.3 Results  
6.3.1 Peak CNIR800 substrate fluorescence signal at 4 hours post-pulmonary 
administration 
At 24 hours post-infection, CNIR800 was delivered by aerosol to mice carrying 
106 CFU of M. bovis BCG in the lungs to evaluate the kinetics of the REF substrate 
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CNIR800 to detect bacterial infection in the mouse lung. Pulmonary delivery of substrates 
improves the signal-to-noise ratio (SNR) by concentrating delivery to the target infection 
site and decreasing background signal from other organs and tissues that could otherwise 
accumulate substrate. Intravital excitation with whole-body imaging was performed every 
2 hours over a 12 hour period (Figure 33 A). In-vivo fluorescence signal from the cleaved 
substrate significantly increased 2 hours post-administration of the substrate with the 
maximum fluorescence at 4 hours (Figure 33 B). Fluorescence signal in the infected 
animal at 8 hours post-administration was not significantly different than the 0 hour 
timepoint, suggesting that the ideal window for imaging by pulmonary delivery of 
CNIR800 is between 2 and 6 hours post-administration of the substrate. Aerosol delivery 
into the airway showed more rapid kinetics than intraperitoneal (IP) delivery of the 
substrate, which had a gradual signal increase from 2 hours until it reached a maximum at 
6 hours post-administration (Figure 33 C). 
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Figure 33: Kinetics of aerosol delivery of CNIR800 (20 μM, 2.5 μl/g) in 
mice infected with 106 CFU M. bovis BCG strain in the lungs. (A) 
Representative whole-body images acquired with intravital excitation at 
time points post administration of CNIR800. (B) Comparison of 
fluorescence signal fold change over signal at initial time point for infected 
and uninfected mice.  *p-value < 0.05, **p-value < 0.01: significantly 
different from fluorescence signal at 0 hour using Student’s two-tailed t-
test. (C) Comparison of kinetics of aerosol delivery and IP delivery of 
CNIR800 
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6.3.2 Dorsal position exhibits the highest SNR at 4 hours post-administration of 
CNIR800 
Groups of mice infected with 106 CFU M. bovis BCG were imaged at 2 and 4 hours 
post-administration of CNIR800 in dorsal and ventral positions on the IVIS stage. SNR 
was calculated at each time point by dividing fluorescence signal detected in infected mice 
by the signal in uninfected mice for each position (Figure 34 C). At 2 hours post-
administration, both positions exhibited a similar SNR. However, at 4 hours post-
administration, SNR was significantly increased in dorsal position as compared to the 
ventral position despite the fluorescence signal being higher in the ventral position. The 
SNR of the images in the dorsal position at 4 hours post-administration was also 
significantly higher than the same position at 2 hours post-administration (P = 0.029). 
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Figure 34: Effect of animal positioning on fluorescence detection and signal to noise 
ratio (SNR) in whole-body imaging with intravital excitation. (A) Representative 
images of mice in ventral or dorsal position acquired at 2 hours and 4 hours post-
administration of CNIR800. Comparison of (B) fluorescence signal and (C) SNR 
(fluorescence signal in infected animals normalized to signal in uninfected animals) in 
different animal positions at different times post-administration of CNIR800. *p-
value<0.05: significantly different from fluorescence of uninfected control group 
calculated by Student’s t-test; +p-value<0.05, ++p-value<0.01: significantly different 
in fluorescence among different imaging time points calculated by two-way ANOVA. 
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6.3.3 Detecting pulmonary infection in mice using BlaC-specific substrate 
Six groups of mice were infected with 101-106 CFU of M. bovis BCG 
intratracheally, and CNIR800 was delivered to the mice via aerosol at 24 hours post-
infection. Mice were first imaged using intravital fiber-optic excitation 4 hours post-
administration of the substrate. Immediately after, mice were imaged using epi-
illumination of whole-body imaging system (IVIS Lumina II) for parallel comparison of 
these systems. As shown in Figure 35, whole-body imaging with intravital fiber-optic 
excitation using CNIR800 provided a threshold of detection as low as ~100 CFU in the 
mouse lung (Figure 6.10C; P = 0.029). Fluorescence signals correlated with the number 
of bacteria present in the mouse lung to 100 CFU (Figure 35 C; R2 = 0.95, P = 0.0008), 
while epi-illumination of the animal only allowed detection of 104 CFU (Figure 36 C, R2 
= 0.36, P = 0.211). Imaging using intravital fiber-optic excitation improved the threshold 
of detection over epi-illumination by ~100 fold.  
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Figure 35: Whole-body imaging using intravital fiber excitation of mice infected with 
10-106 CFU M. bovis BCG strain and labeled with REF substrate CNIR800 delivered 
intratracheally 24 hours post-infection. (A) Representative images 4 hours post-
administration of CNIR800. (B) Scatter plot of fluorescence signal for each animal as 
compared to actual CFU obtained from lung homogenates of same animal. Each dot 
denotes an individual animal. R2 was calculated using linear regression. (C) 
Fluorescence versus grouped CFU from lung homogenates. Bars represent average 
fluorescence of each group and error bars denote standard error. *p < 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001: significantly different as compared to the fluorescence 
in uninfected group, calculated by Student’s two-tailed t-test. 
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Figure 36: Whole-body imaging using IVIS epi-illumination of mice infected 
with 10-106 CFU M. bovis BCG strain and labeled with REF substrate CNIR800 
delivered intratracheally 24 hours post-infection. (A) Representative images 4 
hours post-administration of CNIR800. (B) Scatter plot of fluorescence signal 
for each animal as compared to actual CFU obtained from lung homogenates of 
same animal. R2 was calculated using linear regression. (C) Fluorescence versus 
grouped CFU from lung homogenates. Bars represent average fluorescence of 
each group and error bars denote standard error. *p < 0.05, **p < 0.01: 
significantly different as compared to the fluorescence in uninfected group, 
calculated by Student’s two-tailed t-test. 
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6.3.4 Detecting recombinant strains of bacteria vs. non-recombinant strains of bacteria 
using intravital illumination 
Figure 37 shows the scatter plot of fluorescence signal imaged by whole-body 
imaging using intravital fiber excitation of mice intratracheally infected with 10-106 CFU 
of tdTomato expressing BCG M. bovis bacteria (Figure 37 A) and 10-106 CFU M. bovis 
BCG strain and labeled with REF substrate CNIR800 (Figure 37 B) 24 hours post-
infection. 
As shown in Figure 38, whole-body imaging with intravital fiber-optic excitation 
using either recombinant strains of bacteria (tdTomato-expressing M. bovis BCG) or non-
recombinant strains of bacteria (BlaC-specific substrate) provided a threshold of detection 
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Figure 37: Scatter plot of fluorescence signal for each animal infected with (A) 
tdTomato expressing M. bovis BCG and (B) M. bovis BCG labeled with REF 
substrate CNIR800 as compared to actual CFU obtained from lung homogenates of 
same animal. Each dot denotes an individual animal 
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as low as ~100 CFU in the mouse lung using the parametric Student’s t-test (P = 0.026, P 
= 0.029, respectively). Also, a nonparametric statistical method, Kruskal-Wallis for 
multiple comparisons with the Bonferroni posttest (Dunn’s procedure), provided a 
threshold of detection ~ 103 CFU for both recombinant and non-recombinant strains of 
bacteria (P = 0.002, P = 0.04, respectively).  
  
 
 
 
Figure 38: Fluorescence detected using whole-body imaging using intravital fiber 
excitation versus grouped CFU from lung homogenates for animals infected with (A) 
tdTomato-expressing M. bovis BCG and (B) M. bovis BCG labeled with REF substrate 
CNIR800. Bars represent average fluorescence of each group and error bars denote 
standard error. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001: significantly 
different as compared to the fluorescence in uninfected group, calculated by Student’s 
two-tailed t-test. #p < 0.05, ##p < 0.01, ###p < 0.001: significantly different as 
compared to the fluorescence in uninfected group, calculated by Kruskal-Wallis for 
multiple comparisons with the Bonferroni posttest. 
 
 
 
A) B) 
 95 
 
6.4 Conclusions 
We integrated a fiber optic fluorescence microendoscope into a whole-body 
imaging system for detection of pulmonary infection in-vivo using a NIR BlaC-specific 
fluorogenic substrate. We determined optimal methods for achieving the best SNR, 
including imaging time after fluorogenic substrate administration and the position of the 
animal during imaging. We demonstrated that integration of these optical imaging 
technologies with BlaC-specific fluorescent reporter probes enables sensitive detection of 
bacteria in lungs of living animals down to ~100 CFU (using Student’s t-test), an 
improvement of two orders of magnitude over whole-body epi-illumination. This 
technology can also improve the sensitivity of whole-body optical imaging to enable study 
of early stage bacterial infection, evaluation of therapeutic efficacy, and development of 
preventative treatments. 
These studies are consistent with previous reports showing significant 
improvement of detection sensitivity using intravital excitation to detect tdTomato-
expressing M. bovis BCG in the lungs of live animals [124]. The greater improvement of 
intravital excitation with tdTomato in comparison to CNIR800 can be attributed to the 
shorter excitation wavelength of tdTomato and higher absorption of that wavelength by 
tissue. The use of CNIR800 allows application to native strains of Mtb and the potential 
for clinical translation. Our results also demonstrate improvement of detection threshold 
for REF imaging in live animals compared to both epi-illumination and trans-illumination.  
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CHAPTER VII 
CONCLUSION AND FUTURE WORK 
 
7.1 Major contributions of this dissertation 
We developed an intravital fluorescence microendoscope to detect and quantify 
respiratory bacterial infection, specifically tuberculosis, with high sensitivity. The 
developed imaging technique can be used to enhance study of bacterial pathogenesis in 
physiologically relevant infections, and enable rapid development of diagnostic and 
therapeutic techniques. The microendoscope was integrated to the IVIS whole-animal 
fluorescence imager to enable intravital excitation in the mouse lung with whole-animal 
detection, improve the sensitivity of the epi-illumination whole-animal imager and 
sensitively detect low numbers of bacteria in-vivo. Epi- and trans-illumination methods 
are limited in their ability to get sufficient excitation light into the animal for excitation of 
fluorescent targets deep inside the body. Therefore, by delivering the excitation light 
internally using the intravital microendoscope, the attenuation of the excitation light by 
tissue structures and skin is greatly decreased, allowing for increased delivery of excitation 
light to the region of interest. 
We demonstrated the capabilities of the integrated imaging system using groups 
of animals infected by intratracheal instillation of 101−106 CFU BCG17 (tdTomato-
expressing BCG strain) or 105 CFU BCG39 (same plasmid without tdTomato) as a vector 
control. Using this technique, the threshold of detection was measured as 103 CFU during 
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pulmonary infection (using non-parametric statistical test). Whereas, epi-illumination for 
whole-animal imaging was unable to detect infections, even with 106 CFU present.  
We demonstrated that the integration of these optical imaging technologies with a 
BlaC-specific fluorescent probe, using REF technology, increased the system sensitivity 
to ~100 CFU (using parametric student’s t-test). The low detection threshold enables the 
study of early stage bacterial infection and could allow for longitudinal studies of disease 
progression and therapeutic efficacy with multiple time points in a single animal. Also, 
one of the main advantages of REF technology is that no recombinant strain is needed, 
enabling clinical translation of the technology. 
 
7.2 Future work 
7.2.1 Evaluate therapeutic and vaccine efficacy in animal models 
Having established the ability of the intravital fiber-based microendoscope 
integrated to IVIS whole-animal fluorescence imager to sensitively detect low number of 
bacteria in-vivo, the next step would be evaluation of therapeutic efficacy and 
development of preventative treatments using the developed imaging system. The ability 
of real-time detection of low numbers of bacteria in live animals, make this system suitable 
for study of early stage bacterial infection, and assessment of TB drugs and vaccines.  
7.2.2 Modeling light transport in the mouse lung for enhanced optical detection of 
pulmonary tuberculosis and optimization of the imaging system 
Because of the complex structure of lung tissue, the capabilities of the intravital 
excitation source and external detection are not well-defined. By modeling light transport 
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within the mouse lung and validating the model using optical phantoms, we could predict 
the behavior of the illumination light inside the body, which would facilitate optimizing 
the imaging system in order to improve the detection sensitivity. 
7.2.3 Develop a fiber sensor to sensitively detect the REF fluorescence reporter in-vivo 
Based on the capability of the intravital microendoscope to detect fluorescence 
signal, which is independent from IVIS signal detection, a fiber sensor can be designed 
for use in the development of therapeutics and vaccines without the need of the whole-
animal imaging system. 
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